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ABSTRACT 
Mass spectrometry (MS)-based proteomics has become a powerful technology for the 
identification and quantification of thousands of proteins. However, the coverage of complete 
proteomes is still very challenging due to the high sample complexity and the difference in protein 
concentrations. In data-dependent shotgun proteomics several peptides elute simultaneously 
from the column and are isolated by the quadrupole and fragmented by the collision cell one at a 
time. This method has two major disadvantages. On the one hand, a large number of eluting 
peptides cannot be targeted since the sequencing speeds of current instruments are too slow and 
on the other hand, peptides that only differ slightly in mass and elute together are co-isolated and 
co-fragmented, resulting in chimeric MS2 spectra. Therefore an urgent need for further 
developments and improvements of mass spectrometers remains.  
The aim of this thesis was to co-develop, evaluate and improve novel quadrupole time-of-flight 
(QTOF) mass spectrometers. In my first project I have described the developments and 
improvements of the hardware of the high-resolution QTOF mass spectrometer, the impact II, and 
have shown that this instrument can be used for very deep coverage of diverse proteomes as 
well as for accurate and reproducible quantification. With this kind of instrument, I achieved the 
deepest proteome coverage reported with a QTOF instrument so far. In my second project, a 
QTOF mass spectrometer was additionally equipped with a trapped ion mobility spectrometry 
(TIMS) device up-front. With this instrument configuration a novel scanning method was 
developed, called parallel accumulation – serial fragmentation (PASEF), that yields an up to 10-
fold increase in sequencing speed and that has the potential to overcome the challenges of MS-
based proteomics. In the third project, I have addressed the production of chimeric MS2 spectra. 
My results show that TIMS in combination with MS can already reduce the proportion of chimeric 
MS2 spectra up to two-fold and therefore appears very promising for eliminating ratio 
compression in isobaric mass tagging experiments after further improvements.  
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1 INTRODUCTION 
1.1. Omics studies: from the genome to the proteome 
Proteins play a central role in a variety of biological functions such as catalyzing chemical 
reactions, performing structural roles in cells and mediating cell communication. Proteins consist 
of amino acids linked by peptide bonds. The folded states of proteins are complex, although they 
can be simplified by conceptually breaking them down into different layers of structure. The linear 
amino acid sequence defines the primary structure and this primary sequence then adopts 
secondary structure, defined by the patterns of hydrogen bonds formed between amine hydrogen 
and carbonyl oxygen atoms contained in the backbone peptide bonds of the protein. These local 
patterns are then folded into specific three-dimensional arrangements, the tertiary structure. The 
sequence of each protein is encoded by genes, which in eukaryotic cells is transferred in two 
steps. First, genes are transcribed to generate single stranded messenger RNAs (mRNAs) that 
leave the nucleus and secondly, they are translated by the ribosomal machinery to generate 
proteins.   
For a system-wide view of cellular processes one needs to capture the information encoded by 
the biomolecules that are involved, including DNA, lipids and proteins. Historically, this began with 
the genetic instruction encoded in the genome. In 1977, with the introduction of sequencing 
technologies [1-3] such as electrophoretic sequencing, the first genome was sequenced [4]. Later, 
by a collaboration of different laboratories the first drafts of the human genome was published [5, 
6], a breakthrough in the era of genomics. Information obtained by using sequencing technologies 
allows scientists to identify changes in genes that are associated with diseases and phenotypes. 
Following the development of next-generation sequencing technologies, large-scale acquisition 
of individual genomes can now be performed within a matter of days. But with the information 
gained on the genome level alone, the description of biochemical processes that establish life is 
not complete.  
In the gene to protein hierarchy, the next step is to characterize all mRNA molecules, the 
transcriptome, and their abundances in the cell. This has been achieved on a large-scale with 
DNA microarray technology [7, 8]. This kind of analysis provides an overview of which parts of 
the genome are actually expressed at a given time point and gives an indication on which genes 
are under- or overexpressed or absent between different biological states. Transcriptomes are 
now more commonly obtained in a high-throughput format via next-generation sequencing, a 
technology called RNA-Seq when applied to RNA [9]. Transcriptomics adds the first dynamic 
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information layer to the systems-view of the cell. However, the correlation between mRNA levels 
and protein levels can be low. Therefore it is essential to directly measure the executers of 
biological functions – the proteins.  
In the broadest sense, the proteomes of biological systems (e.g. cell lines, tissues or body fluids) 
describe the entirety of all expressed proteins, including all protein isoforms and modifications, 
and interactions between individual proteins at a given point in time and under specific condition. 
The proteome is a dynamic entity whereas the genome does not change and therefore more 
challenging to determine. In comparison to the powerful methods to measure nucleic acids, 
methods for the large-scale and systematic measurement of proteins took longer to develop. First, 
starting in the 1970s, researcher used two-dimensional gel electrophoresis (separation by 
molecular charge and by mass) to visually observe changes in the proteome [10]. However, this 
technique had severe limitations, such as the fact that only the most abundant proteins could be 
detected and that the identification of those spots was difficult and slow. This situation somewhat 
improved with the advent of the soft ionization techniques electrospray ionization (ESI) [11] and 
matrix-assisted laser desorption/ionization (MALDI) [12], which made it possible to identify protein 
spots one by one from a two-dimensional gel. However, the full potential of these technologies, 
which for the first time allowed the gentle transmission of peptides or proteins into the mass 
spectrometer only came to the fore when electrospray was online coupled to liquid 
chromatography (LC) and algorithms were developed to identify peptides by their fragmentation 
spectra in sequence databases (a technique termed shotgun proteomics) [13]. Many further 
advances in mass spectrometry and adjacent fields were need to enable the large-scale studies 
of peptides and proteins and to create the field of mass spectrometry (MS)-based proteomics [14].  
There are around 20,000 protein coding genes annotated in the human genome [15], however 
the complexity of the proteome caused by alternative splicing of the mRNAs, endogenous 
proteolysis and post-translational modifications (PTMs) means that the number of protein species 
is much greater (Figure 1). MS-based proteomics has now become the tool of choice to identify 
and quantify the proteome of an organism [14]. With the current state of MS technologies, as well 
as in the entire proteomics workflow, from sample preparation to enhanced LC systems and data 
analysis software, it has become possible to achieve a deep coverage of the proteome in a 
reasonable time [16]. However, the complete analysis of all expressed proteins in a complex 
biological system with their differences in abundance, modification state and dynamics remains 
extremely challenging with existing technical instrumentation. The coverage of the full dynamic 
range of protein expression represents one of the major difficulties. For example, proteins in blood 
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plasma differ by more than 10 orders of magnitude in abundance [17], yet only 4-6 orders of 
magnitude can be covered by current LC-MS. In any case, due to the high complexity of a 
biological sample and the limitation in LC separation and acquisition speed of existing mass 
spectrometers, an ultra-deep coverage of the proteome would be very time-consuming with 
current instrumentation configurations, since extensive fractionation of a sample is required to 
decreases its complexity and provide sufficient measuring time. Therefore, an unmet need for 
continued improvements and breakthroughs in proteomic technologies remains. The main aim of 
the work in this thesis was to co-develop, improve and evaluate novel MS technology to make 
MS-based proteomics more competitive with the other omics technologies.  
 
 
 
Figure 1: From the genome to the proteome. The size of the proteome increases by alternative splicing 
of transcripts and post-translational modifications of different proteins.  
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1.2. MS-based proteomics 
In mass spectrometry, the analytes of interest need to be transferred into the gas-phase by an 
ion source. The ions can then enter the mass spectrometer where the mass-to-charge ratios (m/z) 
of ionized analytes are determined. MS has long been applied to many different areas in the 
screening of small molecules but could not analyze peptides and proteins due to the absence of 
techniques that would not destroy them during the ionization process. This changed with the 
introduction of ESI and laser desorption, for which the Nobel Prize in Chemistry was awarded in 
2002. ESI became especially popular since it can easily be combined with high performance liquid 
chromatography (HPLC) by on-line coupling to MS. Thus, ESI is very suitable for the analysis of 
complex peptide mixtures, since peptides are already pre-separated before MS analysis. Different 
improvements and further developments in instrumentations, detailed below, have made mass 
spectrometry very attractive for proteomics, and have created the field of MS-based proteomics 
[14]. In addition to identifying and quantifying proteins, this technology can be applied to measure 
protein-protein interactions, post-translational modifications and even structural aspects of the 
proteome. It has become the method of choice for large-scale studies, due to its fast and high-
throughput qualitative and quantitative analyses of the proteome of cells or organs in a hypothesis 
free and unbiased manner.  
 
1.2.1. Sample preparation workflow for MS-based proteomics  
 
Figure 2: Overview of a typical shotgun proteomics workflow. Proteins derived from cells, tissues or 
body fluids are digested directly or enriched or affinity- purified before digestion. The resulting peptides 
are then separated chromatographically, which can be preceded by peptide fractionation or enrichment 
for specific peptides. Peptides eluting from the column are ionized by electrospray and analyzed in the 
mass spectrometer.  
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In the proteomic field there are two principal approaches: top-down and bottom-up analysis. In 
the top-down approach intact proteins and fragments produced from them are analyzed in the 
mass spectrometer [18-23]. With this method the whole protein sequence can in principle be 
covered and all different protein isoforms and modifications can be detected. However, the 
analysis of complex intact protein mixtures or very large proteins with LC-MS is extremely difficult 
because proteins are often not soluble, are difficult to separate chromatographically and have 
many more charge states. Therefore, the bottom-up approach, which relies on the analysis of 
peptides from a crude proteome digest, is much easier and by far the most-widely used method 
[14, 24-29] (Figure 2).  
Having a robust and very reproducible workflow is absolutely necessary, especially for the 
comparison of different samples conditions. The standard sample preparation workflow in the 
bottom-up approach comprises three major steps: (1) cell- or tissue lysis together with protein 
denaturation, reduction of disulfide bonds and alkylation of cysteines, (2) enzymatic digestion(s) 
and (3) peptide clean-up. Depending on the biological question, a protein population of interest 
can be enriched by affinity enrichment techniques, e.g. protein extraction can be followed by 
immunoprecipitations. Moreover, different approaches have been developed for the enrichment 
of specific peptide classes, especially for low abundant peptides such as phosphopeptides. If very 
deep coverage of a proteome is of interest – both in terms of analyzing the proteins present and 
the coverage of the primary sequence by detected peptides, one can apply different fractionation 
techniques that have been developed and optimized over the last few years. After the sample 
preparation is completed, the peptide mixture is separated via LC which is on-line coupled to the 
MS analysis.  
In the first step of a standard bottom-up MS-based proteomics workflow, proteins are extracted 
from a biological source such as cell lines, tissues or body fluids. In the case of cells or tissues 
this involves lysing the sample. Different protocols are available and which is applied is dependent 
on which protein condition, native or denatured, is desired. Disulfide bonds that stabilize the 
tertiary and quaternary protein structure are broken by a reducing agent (e.g. dithiothreitol, tris (2-
carboxyethyl)phosphine, 2-mercaptoethanol)). The resulting free cysteine residues are 
irreversibly modified by alkylating reagents (e.g. iodo-acetamide or chloro-acetamide) before 
digestion of the protein mixture to avoid formation of new disulfide bonds.  
Next, the protein mixture is digested to peptides with a sequence-specific enzyme. This is usually 
trypsin, which cleaves C-terminal to arginine or lysine, because of its robustness, low price, 
sequence specificity and the fact that the resulting peptides are generally easily detected and 
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sequenced in the mass spectrometer (mass range of 500 to 3,000 Da) [30]. One limitation of using 
trypsin is that more than 50% of the resulting peptides have less than six residues and therefore 
have little protein specific information [31]. To increase the proteome coverage, additional 
proteases such as LysC, GluC, LysN, AspN and chymotrypsin or protease combinations can be 
used [32-36]. Diverse protein digestion protocols have been developed to perform digestion either 
in-solution or in-gel. To remove remaining detergents that could interfere with high performance 
liquid chromatography (HPLC) separation or overwhelm the peptide signal in electrospray (ES), 
an additional clean-up step in the sample preparation workflow is generally applied in most 
protocols. Recently, our group has introduced the in-StageTip method, which was also used in 
this thesis, for performing sample preparation from cell lysis through digested and purified 
peptides in a single reaction vessel fashioned from a pipette tip [37].  
The clean peptide mixtures are extremely complex and are therefore separated as a function of 
their hydrophobicity via reverse-phase, high performance liquid chromatography (HPLC) [38]. For 
proteomics, a chromatography column containing C18 material (reversed-phase C18 silica beads) 
is almost always used. Peptide mixtures are acidified by addition of amphiphilic acid (FA or TFA), 
which promotes their binding to the C18 material. They are eluted from the column by increasing 
the percentage of organic in the mobile phase, which is achieved by gradually changing the mixing 
ratio between aqueous and organic buffer solvent in the buffer. For the analysis of complex 
samples the highest resolution and peak capacity that can robustly achieved are advantageous 
for optimal proteome coverage. Therefore our laboratory employs long columns (around 50 cm) 
and small particle diameters (< 2 µm). Peptides that elute from the column are then ionized by 
electrospray ionization, which generally leaves them with at least two charges (on the basic N-
terminus and terminal arginine or lysine residue) or more for larger peptides, before entering the 
mass spectrometer.  
Very complex peptide mixtures greatly benefit from reducing the sample complexity by 
fractionation, resulting in more identifications or by enrichment using affinity purification (e.g. 
phosphopeptides enrichment) before LC-MS/MS analysis. Adding an extra chromatographic 
dimension of separation in addition to the reverse-phase separation results in an increase in peak 
capacity and a deeper proteome coverage. For this purpose different techniques for fractionation 
have been developed. Widely-used approaches include strong anion- or cation-exchange (SAX, 
SCX) columns [39, 40] as well as hydrophilic interaction liquid chromatography (HILIC) [41]. 
Recently, the combination of high-pH separation in the first dimension and the normal low-pH 
reversed-phase chromatography in the second dimension has become popular [42, 43]. In 
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comparison to SAX, SCX and HILIC, the high-pH reversed-phase method is only partially 
orthogonal, so it would be expected to be less beneficial. However, fractions can be pooled in a 
concatenated way (combining fractions that are sufficiently far apart in the first dimension), so 
that full orthogonality is achieved. If the focus is on a specific peptide population such as 
phosphopeptides, different enrichment methods can be applied, including immobilized metal 
affinity chromatography (IMAC) [44]. This technique is based on chelating agents that are 
immobilized on a polymer matrix. Added metal ions bind to chelating agents and also bind the 
negatively charged phosphopeptides in the sample. Alternatively, metal oxide affinity 
chromatography (MOAC) or titanium dioxide chromatography likewise have high affinity for 
phosphopeptides and can be used for the enrichment of phosphopeptides [45].   
As the next step in the bottom-up MS-based proteomics workflow, the ions generated by ES enter 
the mass spectrometer where mass analysis takes place. For the analysis of complex peptide 
mixtures different mass spectrometer configurations and scan modes are available, which will be 
explained in more detail in the next sections.  
 
1.2.2. Principles of mass spectrometric instrumentation used in proteomics 
Gentle ionization methods 
For the analysis of proteins or peptides in a mass spectrometer, it is necessary to convert them 
into gas-phase ions without destroying them during the ionization process. Over the years 
different ionization methods have been developed, but only two of them are suitable for the 
analysis of larger biopolymers, electrospray ionization (ESI) [11] and matrix-assisted laser 
desorption/ionization (MALDI) [12]. In the latter, the sample is embedded in a solid matrix and 
ions are produced by pulsed-laser irradiation and transferred to the mass analyzer. By its nature 
MALDI is therefore most easily coupled to time-of-flight (TOF) analyzers (see below). Despite 
different advantages of the MALDI method, such as the potential for very high-throughput, by far 
the most-widely used technique for the ionization of biomolecules in the proteomics field is ESI, 
which can be easily combined with liquid chromatography. ESI uses a small capillary at 
atmospheric pressure to which a high voltage is applied. From the needle, charged droplets 
containing solvent and analyte molecules are sprayed, which then evaporate further, ultimately 
generating multiple charged ions that enter the mass spectrometer.  
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Mass analyzers 
For the analyses of (partially) LC separated and ionized peptides different mass analyzers can be 
used. They can be divided into two major groups based on their working principles: beam type 
analyzers that continuously scan ions (time-of-flight (TOF) and quadrupole (Q)) and trap-based 
analyzers that capture ions of interest for a specific time to acquire a mass spectrum (Fourier 
transformation ion cyclotron resonance (FT-ICR), ion trap and Orbitrap) (Figure 3). TOF 
instruments can be interfaced with a MALDI source for performing pulsed analysis. In contrast 
trapping mass analyzers are usually coupled to an ESI source. All instruments have unique 
properties and therefore vary in resolution, mass accuracy, scan speed, m/z range, dynamic 
range and sensitivity. All of them have undergone dramatic improvements with regards to these 
parameters over the last years.  
The resolution (R) of a mass analyzer is calculated by the m/z value divided by the width of the 
peak at half height and gives an indication as to how well two different peaks with different m/z 
values can be distinguished. Mass analyzers with R > 10,000 are generally termed high-resolution 
mass spectrometers. Quadrupole and ion trap analyzers feature a low resolution (R < 1000), while 
TOF instruments can provide a resolution higher than 10,000. The highest resolution can be 
achieved with FT-ICR and Orbitraps (R > 100,000) as they measure frequencies of circulating 
ions with high accuracy. In proteomics, Orbitraps are currently the preferred instruments because 
they combine high resolution with less scanning time (scan speed) than FT-ICR instruments and 
because they are much smaller and more practical.  
Mass accuracy is defined by how far the experimentally determined mass of an ion species differs 
from the actual (calculated) mass and is dependent on the resolution of an instrument. Moreover, 
both parameters are influenced by the signal-to-noise ratio. With an Orbitrap mass analyzer a 
mass accuracy of sub-parts-per-million (sub-ppm) can be achieved [46], while TOF instruments 
are usually in the range of several ppm.  
TOF analyzers achieve a very high scan speed in the range of microseconds. But due to the 
limited number of ions collected in this time, multiple TOF spectra need to be combined, reducing 
the actual scan speed of the instrument to milliseconds (ms) [47]. High-resolution instrument such 
as FT-ICR suffer from the long transient duration and therefore are comparatively slow. In general 
there is an inverse correlation of scan speed and resolution. Orbitrap instruments currently need 
tens of milliseconds to achieve high resolution. 
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Figure 3: Different mass spectrometers used in MS-based proteomics. Dependent on the working 
principle they can be divided into beam type or trap-based analyzer. Adapted from [48, 49]. 
 
The sensitivity of a mass analyzer is dependent on its detection principle. There are currently two 
different methods available: Electron multiplier detectors, usually used by linear ion traps and 
TOF instruments and image current and Fourier transformation (FT)-based detectors, used by 
Orbitrap and FT-ICR analyzers. With the electron multiplier technology single ions can in principle 
be detected, while FT-based detection requires a few charges to achieve a detectable signal-to-
noise ratio [50]. That said, improved electronics and thermal stability have enabled the detection 
of single ions with the Orbitrap mass analyzer, provided the ion is multiply charged and transient 
times are sufficiently long [51]. Currently, the limit of detection (LOD) of mass spectrometers is in 
the attomolar range, although this varies between simple and complex samples. Although TOF 
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mass analyzers in combination with sensitive detectors have the ability to detect a single ion, 
noise is also recorded with the same sensitivity and therefore the quality of the mass spectrum 
may be compromised. In practice, the current generation of Orbitrap instruments appear to have 
a better detection limit than TOF instruments [52].   
 
Over the last decades, hybrid technologies, combining two or more mass analyzers in one 
platform have become popular in proteomics because this yields improved resolution, scan speed 
and sensitivity (Figure 4). Quadrupole mass analyzers with downstream TOF (QTOF) and 
Orbitrap instruments are widely used in the proteomics community and therefore these three 
mass analyzers are explained in more detail below. Dependent on the application a QTOF, triple 
quadrupole (QQQ) or the quadrupole Orbitrap may be the preferred hybrid instrument.  
Quadrupole 
The quadrupole mass analyzer is one of the oldest ones and consists of four parallel rods (Figure 
3A). On each electrode pair a positive or negative direct current (DC) field is applied, which is 
superimposed by a time-dependent radio frequency (RF) field. A quadrupole technically works as 
a filter because ions entering the quadrupole are guided through the quadrupole longitudinal to 
the oscillating electric field caused by rapidly changing the RF field, which in combination with the 
DC field ensures that only ion species within a specific m/z range pass through the quadrupole. 
Switching off the DC field results in the transmission of the entire mass range. Quadrupoles 
feature low mass resolution but this can be improved somewhat by increasing the lengths of the 
rods, applying higher RF frequency, lower acceleration potential and slower scan speeds. A 
common configuration, especially in the targeted proteomics community, is the serial arrangement 
of three quadrupole analyzers. The first one is used for isolation, the next one for fragmentation 
and the last one for mass selection of fragments (Figure 4D). 
The Orbitrap mass analyzer 
The Orbitrap analyzer (Figure 3E) conceived and developed by Alexander Makarov was first 
described in 2000 and commercially introduced in 2005. This device consists of an outer barrel 
shaped and an inner spindle shaped electrode [53]. Ions entering the mass analyzer are trapped 
as they orbit around and along the central electrode. The oscillation along the field axis is specific 
for the m/z value of the ion and can be measured with high accuracy using image current detection 
on the segmented outer electrodes. The recorded image current is processed by Fourier 
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Transformation (FT), transforming the information into a mass spectrum. The principle of the 
Orbitrap is based on the Kingdon trap, which consisted of a wire and an enclosing electrode and 
was presented in 1923 [54], but only with the introduction of the Orbitrap shape and a C-trap [50] 
could ions be properly injected into the Orbitrap, making it possible to use it as a mass analyzer. 
Orbitrap mass analyzers feature high mass resolution and mass accuracy, which have been 
continuously improved during the last 10 years as well as reasonably high dynamic range [55-
58]. Following the first hybrid Orbitrap mass spectrometer, the LTQ Orbitrap (Figure 4A) [50], 
Thermo Fisher introduced the Orbitrap Elite, which featured a dual linear ion trap and a higher 
resolution Orbitrap analyzer (Figure 4B) [57]. The quadrupole – Orbitrap combination was 
introduced with the Q Exactive [59] and the newest version of this configuration is called Q 
Exactive HF, featuring the high-resolution Orbitrap mass analyzer and an improved Fourier 
Transformation algorithm [58, 60]. Since hybrid Orbitrap mass spectrometers achieve a 
combination of high sequencing rate, together with very high resolution and mass accuracy, they 
have become the workhorse in the large majority of proteomics laboratories, especially for 
shotgun proteomics.  
Time-of-flight 
In time-of-flight mass analyzers, the m/z ratios of ions are determined by the time needed to pass 
a field-free drift tube (Figure 3B). Ions enter the flight tube with the same kinetic energy meaning 
that ions with a smaller m/z ratio pass the flight tube faster than those with larger ones.  
The concept of TOF instruments was introduced by Stephens in 1946 [61]. Almost 10 years later 
the first design became commercially available [62]. Due to different developments such as 
progress in electronics and ionization methods towards the end of the 1980s, the TOF instrument 
became increasingly competitive. TOF mass analyzers have several advantages compared to 
other instruments including their high scanning rate, absence of space charge limitations and 
coverage of a large mass range [63]. The major disadvantage of TOF mass analyzers has been 
their lower resolution compared to Orbitrap and FT-ICR instruments, which can be increased by 
a longer flight tube or lowering the acceleration voltage. However, lowering the acceleration 
voltage has the undesired effect of decreasing sensitivity. Nevertheless, developments in the 
electronics, digitizer, and stability of power supplies together with the introduction of delayed 
pulsed extraction and reflectron technology have helped to increase the resolution so that it can 
now be sufficient for proteomics applications. The reflectron technology was first proposed by 
Mamyrin [64] and is integrated in the flight tube to reduce the spatial and kinetic energy spread of 
ions, leading to higher resolution by focusing ions with the same m/z. Reflectrons usually consist 
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of a series of equally spaced grid electrodes, which are connected through a resistive network of 
equal value resistors. They are positioned behind the collision region and are arranged orthogonal 
to the ion path. A further increase in performance was achieved by a two-stage reflectron, which 
uses two homogeneous electric fields of different potential gradients.  
With the introduction of orthogonal acceleration time-of-flight technology by O`Halloran et al. in 
1964 [65] and reinvented by different groups in the beginning of 1990s [66, 67], it became possible 
to combine a TOF instrument with the ESI source. The bottleneck of this combination is that the 
fraction of ions used for analysis is between 5% - 50% because ions are generated continuously, 
but pushed out every few microseconds. Nevertheless with this technology a resolution greater 
than 10,000 as well as improved mass accuracy was achieved. The addition of an RF multipole 
ion guide has yielded a higher ion transmission and sensitivity. A typical QTOF configuration is 
shown in Figure 4C.  
 
Tandem mass spectrometry 
Tandem mass spectrometry (MS/MS) involves two stages of MS. First, intact peptides are 
analyzed in a full scan (MS1) and then ions of desired m/z are selected (termed parent ions or 
precursor ions). Second, isolated ions are fragmented to measure the mass of the generated 
peptide fragments (also termed product ions) in the MS/MS (MS2) spectrum. Tandem mass 
spectrometry can be classified into the two categories: “tandem in space” and “tandem in time” 
[68]. In “tandem in time” mass spectrometers the analysis of parent ions and product ions is 
performed consecutively in the same mass analyzer. In contrast “tandem in space” instruments 
record the mass of parent ions and product ions in different mass analyzers.  
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Figure 4: Overview of different mass spectrometer configurations used in MS-based proteomics. 
Colored squares indicate where precursor isolation (red), fragmentation (green) and detection (orange) 
is performed. Adapted from [69].  
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Fragmentation techniques 
In tandem mass spectrometry product ions need to be generated by fragmentation to obtain 
sequence informative MS2 spectra. Several methods are used in MS-based proteomics, including 
collision-induced dissociation (CID), higher energy C-trap dissociation (HCD) and electron 
transfer dissociation (ETD) [70-73]. In CID as well as HCD collisions between peptides and inert 
gas molecules (e.g. He, Ar, N2) result in bond breakages along the peptide backbone (Figure 5). 
Dependent on the terminus and cleavage site fragment ions are termed a-, b-, c- (when the N-
terminus is intact) and x-, y-, z-ions (when the C-terminus is intact) (Figure 5) [74, 75]. When 
applying CID or HCD, predominantly b- and y-ions are generated. This leads to amino acid 
specific sequence information. HCD uses a higher energy for inducing peptide bond breakages 
in comparison to CID. The entire mass range of fragments is retained and transferred from the 
HCD cell to the mass analyzer (the Orbitrap in case of the Q Exactive). In contrast, when CID is 
performed in an ion trap, the low mass fragments fall outside the stability region and are lost (‘one 
third cut-off rule`) [76]. The low mass region, which is detectable with HCD, is especially important 
for reporter-based quantitation (see below) [77]. While CID and HCD is are very effective for the 
fragmentation of tryptic peptides and peptides with stable modifications, ETD may be preferable 
for intact proteins and longer peptides as well as for peptides carrying labile modifications like O-
GlucNac [78]. In ETD, fragmentation is achieved by using an electron donor, such as anthracene 
or flouranthene anions, for the transfer of an electron to the analyte, resulting in an unstable 
transition state that instantaneously leads to fragmentation, mainly of the c- and z-type.  
 
Figure 5: Peptide fragmentation. According to Roepstorff-Fohlmann-Biemann [74, 75], peptides 
generated depending on the remaining terminal residue a-, b- and c-ions (N-terminus) or x-, y-, and z-
ions (C-terminus). Adapted from [79] 
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1.2.3. Data acquisition techniques in MS-based proteomics 
In addition to the different instrument configurations for LC-MS/MS analysis, different MS 
acquisition modes and data query strategies (spectrum-centric or peptide-centric) have also been 
developed. There are three main operating modes of bottom-up proteomics: data-dependent 
acquisition (DDA, also known as shotgun proteomics), targeted data acquisition (performed 
mostly by selected reaction monitoring (SRM) or multiple reaction monitoring (MRM)) and data-
independent acquisition (DIA). These strategies differ both in the way precursor and fragment 
data are recorded, and in how the acquired data are analyzed. The choice of which method to 
use depends on the biological question. For example, DDA is common in discovery proteomics, 
while SRM is preferably employed for very sensitive and accurate quantification of a small number 
of peptides in many samples.  
Data-dependent acquisition 
In DDA mode, the mass spectrometer scans the entire mass range (usually 300-1650 m/z) such 
that a mass spectrum (MS1) is obtained every few seconds (Figure 6). For identification, each 
peptide needs to be fragmented by tandem mass spectrometry (MS/MS, MS2). Generally, the 5-
20 most abundant peptide peaks of each MS1 spectrum are successively isolated for 
fragmentation one at a time by a quadrupole or linear ion trap (topN cycle) (Figure 6). The decision 
of which precursor is selected for fragmentation is performed in real time by the software of the 
mass spectrometer. To avoid selecting the same peptide species multiple times during elution, a 
dynamic exclusion criterion is applied for a certain time interval. In addition singly charged ions 
can be excluded from the selection because they are usually contaminants and the tryptic 
peptides generally have at least two charges. The quadrupole isolation mass window is kept as 
small as possible to ensure that only the precursors of interest are selected for fragmentation. 
However, very small isolation windows limit transmission, so a common compromise is a selection 
window of about 1 to 2 m/z units (Th). Amide bonds are dissociated and an overlapping series of 
N-terminal (b-ions) and C-terminal (y-ions) fragments are generated. With the fragment 
information from the MS2 spectrum of one peptide, the peptide sequence can be determined by 
searching against a protein sequence database.  
The shotgun or DDA approach is unbiased in that it fragments as many peptides as possible, 
which makes it suitable for discovery studies. It is typically performed on hybrid Orbitrap or 
quadrupole time-of-flight (QTOF) instruments (Figure 4A, B, C). Despite the relatively high 
effective scanning speed of both the QTOFs and Orbitraps, a challenge in DDA is that not all of 
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the eluting peptides may be selected for fragmentation, which is termed the undersampling or 
missing value problem.  
 
Figure 6: The data-dependent acquisition (DDA) mode. In DDA, the most abundant peptides from each 
full scan (MS1 scan) are selected one at a time by the quadrupole and fragmented in the collision cell. 
Information from the acquired MS2 spectra are used to match against a protein sequence database to 
identify the peptides present.  
 
Targeted data acquisition 
The selected reaction monitoring (SRM) or the closely related multiple reaction monitoring (MRM) 
approach are the most widely used methods in targeted proteomics. They determine the 
abundance of predefined peptides by repeatedly recording the transitions to fragment ions, which 
are also determined in advance, over the whole LC elution profile of the peptide. Fragment ion 
chromatographic signals of individual transitions are used to determine qualitative and 
quantitative information. This approach aims to ensure that peptides of interest and their 
fragments are measured in each sample at high sensitivity. Usually this method is carried out 
mostly on robust and sensitive triple quadrupole instruments (Figure 4D). Here, the first and third 
quadrupole act as mass filters, while the second one is used for fragmentation. However, due to 
the low resolution of the quadrupole, a main drawback of the method is its limited specificity which 
raises the issue of quantifying unrelated signal or noise instead of the intended target and requires 
extensive method optimization for each peptide. To improve specificity, parallel reaction 
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monitoring (PRM) or MS/MSAll has recently been introduced [80]. Conceptually, the third 
quadrupole of the triple quadrupole instruments is replaced with an Orbitrap mass analyzer, 
allowing the recording of high resolution MS2 signals with high accuracy over time. In the targeted 
approaches short gradients of about 30 min are commonly used and pre-fractionation is avoided 
for medium abundance peptides, which is important for high-throughput experiments. However, 
the development of peptide-specific assays is time consuming since the most promising peptides 
per protein and the most intense transitions need to be found. Moreover, all parameter settings 
need to be optimized for the instrument type used. Another disadvantage is that in practice 
generally less than 100 predefined peptides can be analyzed with MRM.  
Data-independent acquisition 
The aim of the DIA method is to continuously acquire MS/MS spectra to cover the complete tryptic 
peptide mass range. This is achieved by using a much wider quadrupole isolation mass windows 
for further fragmentation since the instrument scan speed is too slow to cover the complete mass 
range with a small mass window – and this would also severely limit sensitivity. Due to the fact 
that multiple precursors are selected and fragmented, the resulting MS2 spectra comprise 
fragments from many different precursor ions. The acquired data are therefore analyzed using 
specialized database searching or spectral library matching strategies in which fragment and 
precursor ions clustered based on their chromatographic peak shapes. DIA can be performed on 
different hybrid mass spectrometer such as QTOF and Q Exactive (Figure 4B, C). A popular DIA 
approach was introduced in 2012 by AB Sciex and the Aebersold group and called sequential 
windowed acquisition of all theoretical mass spectra (SWATH-MS) [81]. This method was 
demonstrated on a QTOF instrument and data were generated by repeatedly cycling through 32 
consecutive 25 Da quadrupole mass isolation windows within the 400-1200 m/z mass range. Data 
analysis was performed by using only the information of the chromatographic peak shapes of 
precursor and their fragment ions signals.  
 
1.2.4. Computational proteomics 
In MS-based proteomics very large datasets are generated. For instance, using our set-up the 
analysis of a complex peptide mixture within a 90 min gradient run, typically generates more than 
7000 MS1 scans and 75,000 MS2 spectra. For the analysis and interpretation of such large 
datasets, specialized computational workflows have been developed. In our laboratory, Jürgen 
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Cox has developed the freely available MaxQuant package software, which has since become a 
standard in the community [82, 83]. In this thesis the MaxQuant environment was used exclusively 
and therefore it will be described in more detail. The analysis of shotgun proteomics data can be 
divided into four steps: (1) feature detection and processing, (2) peptide identification, (3) protein 
identification and (4) quantification. Each of these will be described here and quantification will be 
described in-depth in the next section.  
 
Figure 7: Computational proteomics: From feature detection to protein identification. (A) Peptide 
features in LC-MS/MS are plotted based on m/z, retention time and intensity. To achieve accurate 
measurements, recalibration of the mass and retention time can be performed. (B) Peptide 
identification based on database searching. (C) Assignment of peptides to their corresponding proteins. 
Adapted from [84].  
 
Feature detection and processing: As a first step, peptide features are extracted from the raw 
data by detecting them in a three-dimensional area (Retention time, m/z, intensity) (Figure 7A) 
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and fitting them to peptide isotope patterns typical of that mass. To ensure very accurate 
measurements, MaxQuant applies algorithms to recalibrate the measured peptide masses on the 
basis of a subset of unambiguously identified peptides.  
Peptide identification: Sequencing a peptide can either be accomplished de novo or by matching 
the MS/MS data to sequence databases. In the de novo approach the mass difference between 
each peak is calculated and assigned to a specific amino acid with that mass, ultimately leading 
a partial or total peptide sequence. This method can in principle even determine novel peptides 
and proteins that are not annotated or not present in the databases. However, de novo 
sequencing relies on complete fragment information, whereas database matching more easily 
deals with sparse information and is therefore more commonly used in shotgun proteomics. 
Precursor mass information from the full scans and MS2 spectra are used to compare them with 
theoretical spectra that are generated by an in-silico digest of the entire protein sequence 
repertoire of a specific organism (Figure 7B). The search engine is provided with digestion 
parameters such as protease specificity, number of allowed missed cleavages and fixed and 
variable (e.g. post-translational modifications) modifications. While it may seem advantageous to 
allow many such variations, this results in a combinatorial increase of the search space and 
negatively affects search specificity. Peptides are identified by scoring each obtained MS2 
spectrum to a peptide in the database with a probability-based strategy. Peptides can be falsely 
assigned, most commonly caused by low quality MS2 spectra (few fragments and/or low ion 
intensity) or MS2 spectra containing co-fragmented precursors. To control for this, different 
techniques have been developed, including the target-decoy approach (reviewed in [85]). This 
method directly produces a false discovery rate (FDR) from the number of reverse peptide hits, 
which is generally set at 1%. Peptide identifications can be transferred by the so-called “match 
between runs” feature in MaxQuant, which transfers the identification of a sequenced peptide 
from one MS run to others where the peptide was only detected in the MS1 scan but not 
sequenced. This reduces the ‘missing value’ problem in shotgun proteomics. 
Protein identification: After identifying peptides, they need to be assigned to the proteins that they 
originated from (Figure 7C). This ‘protein inference problem’ is non-trivial because not every 
peptide is unique for a specific protein but instead may occur in several proteins. In MaxQuant, 
proteins are grouped together into a ‘protein group’ when sharing one or multiple peptides 
together and no distinguishing peptides. Apart from the peptide FDR, a FDR on the protein level 
needs to be applied. The protein FDR works analogously to the peptide FDR: protein groups are 
ranked in order of the combined peptide spectrum match (PSM) scores and the ranked list of 
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protein groups is cut at the point where it contains 1% protein groups that match to the decoy 
database.  
Protein quantification: After peptide and protein identification, the relative or absolute amount of 
each protein needs to be calculated and this is explained in the next section.  
 
1.2.5. Quantitative proteomics 
Overview of quantification techniques 
In proteomics experiments, it is not only the presence or absence of thousands of proteins that is 
of interest, but even more their absolute and relative amounts, which is indispensable to 
understand their functional role in biological systems. In relative quantification the amount of 
proteins is compared between several samples, and in absolute quantification, the total amount 
of proteins in a sample is measured (for instance in femtomoles or in ng/mL in a body fluid). Over 
the years different approaches for relative and absolute quantitation have been developed and 
they can be categorized into label-free quantification and label-based quantification. Depending 
on the quantification approach, samples are combined at different stages of the sample 
preparation processing (Figure 8), resulting in differences in the accuracy and robustness of 
quantification. Moreover, depending on the strategy, the quantitative information is extracted 
either at the MS1 or MS2 (MS/MS) level (Figure 9). 
Label-free quantification 
In label-free quantification (LFQ), samples are not mixed and each sample is measured in 
separate MS runs (Figure 8). Due to the fact that each sample is treated separately until data 
analysis, artifactual quantitative differences can arise during sample processing and therefore the 
label-free strategy can be less accurate in comparison to the label-based techniques. Ensuring 
highly reproducible sample preparation and LC-MS measurements together with effective data 
analysis tools can nevertheless enable quite accurate quantification, which is also evident in this 
thesis. Peptide abundance can be calculated in different ways. The most common is the intensity-
based LFQ approach. To enable accurate quantification, peptide peaks have to be distinguishable 
on the elution time and mass dimensions and therefore performance is best if data were acquired 
on high resolution mass spectrometers together with high resolution LC separation. The LFQ 
method is based on the assumption that the peak intensities of peptides correlate in a linear 
manner with the peptide concentration over a wide range of concentrations [86]. Label-free 
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strategies have existed in various forms since the beginning of electrospray ionization but have 
been refined over time (see for instance Bondarenko et al. [86] and Cox et al. [87]). In MaxQuant, 
the peptide features are detected in all MS measurements within a project, before aligning all runs 
on the basis of their retention times to make them comparable between each other (Figure 9). In 
this way even non-linear shifts in chromatography can be handled. In the next step the matching 
between runs feature is applied in MaxQuant, transferring peptide identifications from a run in 
which the peptide was identified to others in which the peptide was present put not sequenced 
[88]. This feature helps to overcome the limitation of shotgun proteomics where only the most 
abundant peptides are selected for fragmentation and can therefore be identified (the 
undersampling or missing value problem mentioned above). Moreover, this strategy increases 
the number of peptides that can be quantified. Importantly, the matching between runs feature 
can only be applied effectively if accurate mass measurement and corrected retention times are 
available. The raw intensities are then normalized on a global scale to avoid differences due to 
potential differences in overall sample amount, i.e. due to pipetting errors. This is done by 
assuming that the overall changes between all proteins must be zero. By considering all available 
pairwise peptide ratios, the protein intensity profile of each protein can be determined from the 
peptide intensities over all samples.  
The main advantages of label-free quantification is that no extra sample handling is necessary for 
quantification and that therefore the technique can be applied to any sample. The absence of 
labeling also makes sample preparation very economical. Furthermore, in principle, the number 
of samples that can be analyzed and compared is unlimited.   
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Figure 8: Approaches for relative quantification and their corresponding sample preparation processing 
strategies. The two differently colored boxes (blue and green) indicate two different samples to be 
compared. In metabolic labeling, samples are combined directly after obtaining them. All sample 
treatment steps are applied equally, resulting in very accurate quantification. In chemical labeling, 
samples are combined at a later stage of the workflow, potentially leading to less accurate quantitation. 
In the label-free approach samples are not combined for MS analysis at all which requires a very 
reproducible and robust sample preparation workflow. Whereas metabolic labeling can be multiplexed 
to some degree and chemical labeling can be highly multiplexed, label-free quantification requires 
separate and even repeated analyses per sample. Adapted from [89, 90]. 
 
Label-based quantification 
In label-based quantification approaches, different stable heavy isotopes such as 13C, 15N, 2H (D) 
are used. Usually all samples are heavy-labeled while using a light control. Introduction of the 
stable isotopes causes peptides to differ in their mass while their other physicochemical properties 
remain unchanged. After labeling, all samples can be combined and are treated equally during 
further sample processing and are analyzed together in the same LC-MS/MS runs. Depending on 
the labeling strategy samples are combined at early or later stage in the sample preparation 
workflow (Figure 8). The number of samples that can be combined and analyzed together, termed 
multiplexing, is dependent on the labeling technique. It typically ranges between 2 and 10 but 
analysis of 54 samples has also been shown by combining metabolic and chemical labeling [91], 
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potentially resulting in an enormous reduction of MS measurement time. Label-based 
quantification approaches can be divided into three main categories: metabolic labeling, chemical 
labeling and spike-in of labeled standards.  
In metabolic labeling, the metabolism of living cells or organisms is used to introduce stable 
isotopes by feeding them with heavy-isotope-modified amino acids. In stable isotope labeling with 
amino acids in cell culture (SILAC) heavy-isotope substituted forms of arginine and/or lysine are 
used [92]. SILAC can also be employed with light, medium and heavy labeling, enabling direct 
comparison of three states. After labeling, samples are mixed at the earliest possible stage of the 
sample preparation workflow (Figure 8). As there are no artificial changes between samples 
during further sample preparation, highly accurate quantification results can be obtained. The 
samples are distinguishable on the MS1 level (Figure 9) because after digestion with trypsin 
peptides with at least a single labeled amino acid are generated – the C-terminal arginine or 
lysine. The mass spectrometer then detects each peptide in its light, medium (if applicable) and 
heavy version, which reflects the relative amount of each protein. Although considered the gold 
standard in quantitative proteomics, there are several drawbacks using this technique. Firstly not 
all sample types can be SILAC labeled, such as clinical samples and organisms that can readily 
synthesize their own lysine and arginine. Secondly, only two to three sample can be analyzed 
together. Thirdly, the combination of multiple samples can lower the number of identifications due 
to the increase in complexity introduced by the different isotopic peaks at the MS1 level. 
Additionally, as in any multiplexing technique there is a dilution effect as the total sample amount 
loaded onto the columns comes from three different samples and therefore the ion intensities are 
distributed between several isotopic peaks. Some of these challenges have been addressed by 
technologies such as super-SILAC [93] or neutron-encoded mass signatures for multiplexed 
proteome quantification (NeuCode) [94].  
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Figure 9: Extraction of information in different quantitative approaches. Depending on the approach, 
quantification is performed on the MS1 or MS2 (MS/MS) level. In the label-free approach peptide 
intensities are compared across runs at the MS1 level, and in stable isotope-labeling such as SILAC or 
dimethyl labeling peptide intensities are compared between the differentially labeled peptides within 
a run, also at the MS1 level. In contrast, in the reporter ion-based approaches quantification is 
performed on the reporter ion intensities at the MS2 level. Adapted from [84]. 
 
Chemical labeling 
An alternative approach to metabolic labeling is chemical labeling, which can be applied to any 
sample. In chemical labeling approaches, the stable isotopes are introduced at a later stage of 
the sample preparation workflow in a chemical reaction (Figure 8). This can happen either at the 
protein or peptide level. Different chemical labeling strategies have been developed, including  
isotope-coded affinity tags (ICAT) [95], isobaric tag for relative and absolute quantification 
(iTRAQ) [96] and tandem mass tag (TMT) [90]. TMT is described in more detail since it plays a 
major role in this thesis. Isobaric tagging, including iTRAQ and TMT, utilize molecular tags that 
are not discriminable at the MS1 level because each of the labels confers the same overall mass 
addition. Fragmentation yields two types of product ions at the MS2 level: reporter ions specific 
to the label and peptide backbone fragment ions (Figure 9). Quantification is based on the relative 
intensities of the reporter ions. Advantages of chemical labeling are the degree of multiplexing, 
high precision in the reporter ion pattern and universal applicability. Disadvantages include 
expensive reagents, ensuring complete reaction without side reactions and the dilution of the 
sample between the combined samples.  
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Tandem mass tag (TMT) 
Different TMT reagents are available such as TMTzero, TMTduplex, TMT 6-plex and TMT 10-
plex. These share the same structure but differ in the number and positioning of 13C and 15N 
isotopes in the reporter region (Figure 10). In TMT 6-plex, the six tags generate their specific 
reporter ion at m/z 126, 127, 128, 129, 130 and 131 (Figure 10) and both QTOFs and Orbitraps 
can easily detect ions in the low m/z range with this unit mass spacing. In the higher multiplexed 
versions of TMT, the mass difference between the reporter ions is very small and mass 
spectrometers with very high resolution are needed. Currently only Orbitrap instruments can 
achieve the resolution required to resolve the 6 mDa differences necessary to measure all 10 
channels of TMT 10-plex [97]. Advantages of isobaric quantification strategies at the MS2 level 
include that there is no dilution effect at the MS1 level due to multiple samples, no redundancy in 
MS/MS scanning events due to multiple precursor ion species [98] and it circumvents the C-trap 
capacity limit by not storing the entire mass range for quantification [99-101]. A major drawback 
of reporter ion-based quantification (e.g. iTRAQ and TMT), which has prevented more general 
adoption is the fact that quantification accuracy is severely limited by the so-called ratio 
compression problem [102-104], which will be described next.  
Ratio compression: Accurate quantification of TMT-labeled peptides can only be achieved when 
a single precursor ion is selected for fragmentation. Co-eluting peptides within the same isolation 
window used for selection followed by fragmentation of specific ions results in under- or 
overestimation of the true peptide ratios in the measured samples (Figure 11). This is because 
co-fragmented peptides will all contribute to the same reporter ions, distorting the measured 
ratios. Another reason for inaccurate quantification is that artefactual spectral peaks can be 
present and interfere [105]. To overcome those challenges different strategies have been 
developed.  
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Figure 10: Tandem mass tag (TMT). (A) Chemical structure of the TMT 6-plex reagents. Blue asterisks 
indicate heavy isotope positions of 13C and 15N. Tags feature different distributions of isotopes between 
the reporter and balancer groups. (B) Workflow of a typical isobaric tagging experiment. Here, TMT 6-
plex is used to label peptides from 6 different samples. Those are combined after labeling and analyzed 
together in the mass spectrometer. In the full MS scan (MS1) differentially labeled peptide ions are not 
distinguishable but after isolation and fragmentation of a specific peptide species quantification can be 
performed on the reporter ion intensities. Adapted from [106].  
 
Overcoming ratio compression: Multiplexing strategies promise high-throughput, hence there is a 
great interest in solving the ratio compression issue. The higher the complexity of the sample, the 
more frequently co-elution plays a role, therefore ratio compression should be partly ameliorated  
by fractionation [107], however, in practice further fractionation actually worsens the problem 
perhaps because more low level peptide species contribute. Very narrow MS/MS isolation width 
settings also decrease interference from other ion species to some extent [103]. Moreover, the 
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selection of peptides followed by fragmentation at the apex of the LC peaks reduces co- 
fragmentation [103]. Although these methods can reduce the ratio compression problem, they do 
not solve it entirely. An approaches that more successfully reduces interfering ions in complex 
mixtures is the so-called MS3 method [108] and its refinement, the synchronous precursor 
selection (SPS) method [109]. In MS3, precursors are selected and fragmented like usual and 
then peptide fragments are selected and fragmented to generate MS3 spectra. The major 
disadvantage of applying MS3 is that the cycle times become longer than when performing MS2 
only, sensitivity is reduced and currently, selection of fragmentation products from different, co-
selected precursors can still lead to ratio compression.  The SPS method can only be performed 
on linear ion trap - Orbitrap-based instruments and this combination is currently exclusively 
available on the very high end FUSION instrument.  
It has been suggested that QTOF instruments equipped with ion mobility have the potential to 
eliminate interference of co-eluting peptides as IMS-MS separates ions based on shape, m/z and 
charge [110], and this is a major aim of this thesis.  
 
 
Figure 11: The ratio compression problem. Peptides that elute at the same time from the column and 
are selected by the quadrupole in the same isolation mass window are co-fragmented in the collision 
cell, resulting in chimeric MS/MS (MS2) spectra, with contributions of all of them. The reporter ion 
signals do not derive only from the targeted peptide species, leading to quantification errors. 
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1.2.6 Challenges in shotgun proteomics 
Recent advances in proteomic technologies have made MS-based proteomics a central research 
tool. However, truly complete proteomes are still elusive, mainly due to the high complexity and 
dynamic range of biological samples with their range of post-translational modifications. More 
than 10,000 proteins are typically present in each biological sample at one specific condition and 
after digestion the complexity of analytes increases by at least one order of magnitude, because 
each protein generates tens to hundreds of peptides. The tremendous challenge of the dynamic 
range is best illustrated by plasma where protein concentration differs by more than 10 orders of 
magnitude, i.e. between albumin and low level cytokines [17], while LC-MS typically covers a 
dynamic range of 4-6 orders of magnitude [29]. Moreover in blood plasma the 22 most abundant 
proteins constitute about 99% of the total protein mass. Depletion of the high abundant proteins, 
fractionation techniques and enrichment approaches that target a specific sub-proteome (e.g. 
phosphopeptides) together with improvements in high resolution liquid phase separations and MS 
technologies have made it possible to cover the proteome in greater dynamic range and depth, 
but often introduce their own challenges. For instance, while extensive fractionation of a sample 
reduces complexity and results in a better proteome coverage [42], it also requires more 
measurement time, which reduces throughput. Besides reducing the complexity of the biological 
sample by fractionation or enrichment, high resolution in on-line LC separation helps to address 
these challenges. Very high pressure, long columns (50 cm) with small porous particles (<75 µg) 
and long gradients have improved the number of identifiable proteins even in single runs without 
any depletion or fractionation [111-113]. However, these developments still do not allow complete 
proteome characterization, and a premise of this thesis is that this could be achieved by a different 
approach – essential the introduction of third dimension of separation in a compact and efficient 
way (see below). In the following, the challenges of shotgun proteomics that could be addressed 
by such a novel approach are described.  
The above mentioned ‘missing value’ or ‘undersampling’ problem in shotgun proteomics stems 
from the fact that a finite number of the most abundant precursor can be selected for 
fragmentation at any time and that this process is partially stochastic. An increase in sequencing 
speed may help to an extent but does not solve the issue completely since the complexity of the 
sample is too high and since the peptide separation via HPLC alone is insufficient so that multiple 
peptides at different concentrations co-elute from the column at the same time. Illustrating this, 
our group showed that more than 100,000 isotope features could be detected with our mass 
spectrometric configurations, but that only 16% of them were actually selected for fragmentation 
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and even less identified [114]. While an increase in sequencing speed or an increase in ion current 
would help to successfully target more peptide features, co-eluting peptides with a similar m/z or 
a small mass difference would still be isolated together by the quadrupole and fragmented in the 
collision cell, resulting in chimeric MS2 spectra (Figure 11). This decreases the potential to identify 
the peptide with high confidence. Already now only about 50% of all acquired MS2 spectra can 
be identified. This is partly a result of chimeric MS2 spectra but also due to low quality MS2 
spectra. Although several search engines can now handle chimeric MS2 spectra and can identify 
multiple peptides from one MS2 spectrum, this strategy loses effectiveness when the intended 
peptide is of low abundance compared to the co-fragmented one. Small mass isolation windows 
(currently down to 0.4 Th) also help to some extent but there is a limit to the size of the window 
because making it too small would lead to less ion transmission efficiency and hence reduced 
sensitivity. In summary, co-elution and co-fragmentation of several peptides result in a decrease 
in peptide and protein identification (in addition to the problem of ratio compression explained 
above). 
Another challenge in MS-based proteomics is the identification of peptide variants and post-
translational modifications. This is currently either not part of the standard workflow at all or 
achieved by PTM-specific workflows. However, improvements in MS-based proteomics 
technology could ideally allow detection of such variants in a standard and generic way. 
For all the reasons given in this section, further improvements on the existing technologies are 
absolutely necessary. In particular, we were searching for a way to increase fragmentation speed 
without losing sensitivity as well as a way to reduce the extent of chimeric MS2 spectra and ratio 
compression. For this purpose I have co-developed, improved and evaluated a novel mass 
spectrometer for quantitative proteomics.  
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1.3. Ion Mobility Spectrometry (IMS) – Mass Spectrometry (MS) 
1.3.1 General principles 
Ion mobility spectrometry (IMS) separates ions in the gaseous phase based on their size and 
shape using an electric field. Classical studies of the famous physicist Paul Langevin are a basis 
for this separation technique [115, 116]. Over the past several decades, IMS instrumentation has 
been applied to very diverse areas such as chemical weapons monitoring [117], detection of 
dangerous and illegal substances [118], food quality analysis [119], drug detection [120] and to a 
limited degree, biological analysis [121]. There are different ion mobility principles, which can be 
categorized into dispersive ones that capture the entire ion mobility range and selective ones that 
pass a particular ion mobility range. The dispersive techniques include drift-time ion mobility 
spectrometry (DTIMS), travelling wave ion mobility spectrometry (TWIMS) and trapped ion 
mobility spectrometry (TIMS) while the selective techniques are represented by field asymmetric 
waveform ion mobility spectrometry (FAIMS). Ion mobility separation typically happens in 
milliseconds, which readily fits between the LC separation time (seconds to minutes) and the 
mass spectrometer scan time (operating on the microsecond time scale). In combination with MS 
it can be used to determine structural information, gain insights into the conformational dynamics 
of a protein or protein complex and resolve isomers of the same chemical compound that are not 
distinguishable by mass spectrometric measurement alone [122]. For proteomics applications, 
the potential increase in peak capacity, increased dynamic range and improved signal-to-noise 
ratio are most attractive [123].  
Hybrid IMS-MS instruments were first described over 50 years ago [124-126]. Due to 
improvements on the MS as well as the IMS side, IMS-MS has shown great potential for the 
analysis of complex mixtures in proteomics [127-131], glycomics [132-134], metabolomics [135-
137] and petroleomics [138, 139]. Therefore four different IMS techniques that can be combined 
with MS are described in more detail in the following.  
In IMS ions are separated based on their structure and shape, which together determine the 
collision cross section (CCS). In more detail, the cross section of an ion Ω is related to the average 
shape of the ion and is determined by the collision rate with a buffer gas. Due to fewer collisions 
between compact ions and the buffer gas in comparison to elongated ions (e.g. planar structures, 
helices, etc.), compact species have higher ion mobilities than the ions with a more open structure.  
 
 31 
 
The mobility of an ion is determined by [140]: 
K = v/E 
Where K is the mobility of an ion, v the speed an ion moves and E the electric field to which it is 
subjected.  
The mobility is dependent on the experimental temperature and pressure. Therefore a reduced 
mobility 𝐾0 (normalized to standard temperature and pressure) is used. According to the Mason-
Schamp equation [141], Ω can be calculated for a classical linear drift tube as follows: 
𝛺 =  
3𝑧𝑒
16𝑁
(
2𝜋
𝑘𝑏𝑇
)
1
2
1
𝐾0
 
where 𝑧 is the charge state of the ion, 𝑒 is the elementary charge, N is the number density of the 
drift gas, 𝑘𝑏 is the Boltzmann constant, and 𝑇 is the gas temperature. The low field limit is the 
range in which this relationship between Ω and 𝐾0 is valid. The determined CCS provides 
characteristic information of the structure of each ion. This data can be used to compare it to other 
structural techniques such as nuclear magnetic resonance spectroscopy. CCSs can be precisely 
measured, usually to a few percent [142-144], Note, however, that CCS values need not be 
constant even within the low field limit as they will depend on the gas, and as ions may start to 
unfold and change structure as they are heated.   
 
1.3.2. Drift-time Ion Mobility Spectrometry – Mass Spectrometry 
DTIMS is the oldest IMS technique and is implemented as a series of stacked-ring electrodes to 
which an electric field is applied in the direction of the drift tube axis. Ions in a carrier gas enter 
the drift tube, which is filled with a buffer gas - usually helium (but nitrogen or argon can also be 
used), and are guided through the drift tube by applying a static and uniform electric field (usually 
5-100 V) (Figure 12A). The time needed for an ion to pass through the tube depends linearly on 
its CCS. The measured drift time of each ion type is then used for the calculation of the CCS 
according to the Mason-Schamp equation given above [145].   
One issue of early developed DTIMS instruments was their low duty cycle (percentage of ions 
that could be analyzed compared to total ions produced). This limitation has been partially 
addressed by different improvements such as ion funnel traps [146-150] and using higher 
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pressure. Additionally, applying a radio frequency for ion confinement has led to better 
transmission of ions [149, 151-153].  
Clemmer and coworkers developed the first dispersive IMS-MS instrument [154]. Nowadays, 
different DTIMS instruments are commercially available from TOFWERK, Excellims and Agilent, 
for example, and they usually address low molecular weight applications. DTIMS-MS instruments 
consist of a short drift tube into which ions are injected and where – after separation - they are 
detected by a compact mass spectrometer. In case of a TOF instrument, the time the ions need 
to pass from the entrance of the drift tube to the TOF pulser determines the drift time. Ideally all 
ions are then guided into the TOF. With DTIMS-MS a resolving power up to around 250 [122] can 
be achieved but usually it is in the range of around 60-80 [143]. Using a longer drift tube improves 
resolving power.  
 
Figure 12: Schematic of different commercially available ion mobility devices. (A) In drift-time ion 
mobility spectrometry (DTIMS) a linear electric field is applied to a drift tube containing a buffer gas. 
Separation is achieved because depending on their size, ions have greater or fewer collisions with the 
buffer gas. (B) Travelling wave ion mobility spectrometry (TWIMS) uses a travelling voltage wave to 
push ions through the device. Separation is achieved because higher-mobility ions tend to be carried by 
the wave, whereas ions with lower mobility roll over the wave. (C) Field asymmetric ion mobility 
spectrometry (FAIMS) uses an alternating asymmetric electric field so that ions drift through the 
electrodes at different rates. By applying a compensation voltage, ions of only one specific cross section 
are repelled and refocused and are prevented from colliding with the electrodes. Small ions are in red, 
large ions in blue. Adapted from [155]. 
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1.3.3 Travelling Wave Ion Mobility Spectrometry – Mass Spectrometry 
Travelling wave ion mobility spectrometry (TWIMS) was introduced a decade ago by Waters 
Corporation [156-159]. The TWIMS device consists of a series of planar electrodes, termed 
stacked ring ion guides that are arranged orthogonally to the transmission axis (Figure 12B, 13). 
In contrast to the drift tube, TWIMS applies a dynamic electric field in a travelling wave manner 
[156]. Ions are radially confined by RF voltages at the electrodes, while a superimposed DC 
voltage creates the travelling wave. A wave moves from the entrance of the T-wave ion guide 
until the exit and pushes ions toward the detector. Dependent on the size and shape ions are 
picked up by the wave and slowed down by this action. Here, the measured mobility is dependent 
on how often a wave passes the ion and how many waves are needed for an ion to traverse the 
T-wave ion guide, which is filled with gas [156, 160]. Ions with higher mobility are carried by the 
wave and therefore pass the TWIMS device faster than low mobility ions, which roll over some of 
the waves. This technique has a higher ion transmission efficiency compared to other devices. 
For the determination of CCS with a TWIMS device, calibration of the drift time under defined 
conditions is absolutely necessary because the changing electric field means the relationship 
between Ω and K0 is not valid in the Mason-Schamp equation. For this reason analytes with known 
CCS are used for calibration.  
The T-wave device is available in combination with a TOF instrument, as the Synapt-G2 mass 
spectrometer from Waters Corporation (Figure 13). Here, the ion mobility device is located 
downstream of the analytical quadrupole, which is different to the other wide-spread IMS-MS 
instruments in which ions are first accumulated before they are injected into the ion mobility device 
followed by MS analysis. In those instruments ion mobility separation is performed in the stacked 
ring ion guides described above and they can also be used for fragmentation before mobility 
separation. One advantage of TWIMS-MS instruments is that ion separation is dependent on the 
height and the velocity of the traveling wave. By altering these parameters, specific ions can be 
targeted with high mobility resolution. Synapt-G2 instruments are used in different fields [161, 
162], however the currently achievable resolving power of around 45 is relatively low [158].  
Scientists at Waters have previously described a DIA method termed MSE in which the entire 
mass range is fragmented and peptide are identified by correlating precursor mass elution profiles 
with those of multiplexed fragments [163, 164]. An ion mobility based refinement, HDMSE is used 
on TWIMS-MS instruments. Here, parallel fragmentation of multiple precursor ions is performed 
and ion mobility arrival times of parent ions and fragment ions are aligned, followed by database 
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searching. With this method over 50% more peptides and proteins could be detected in 
comparison to the MSE method alone [165], indicating the potential of adding ion mobility 
information. Instead of using a fixed collision energy for the fragmentation of all present 
precursors, an ion mobility-dependent collision energy can be used, resulting in a significant 
increase in fragmentation efficiency and peptide and protein identification rate [130].  
 
 
Figure 13: Hybrid quadrupole/TWIMS/TOF mass spectrometer (Synapt HDMS mass spectrometer from 
Waters). Adapted from [159].  
 
1.3.4 Field asymmetric Ion Mobility Spectrometry – Mass Spectrometry 
The field asymmetric ion mobility spectrometry (FAIMS) device consists of two electrodes, across 
which an electric field is applied (Figure 12C). The two main electrode configurations are planar 
[166] and cylindrical [167]. In the planar configuration ions are separated in high electric fields (> 
7500 V/cm). Ions enter the device perpendicular to the electric field and collinearly to the drift gas. 
Separation is achieved by dispersion and compensation voltages. By using alternating high and 
low electric fields, ions radially drift as they traverse the electrodes. If a dispersion voltage was 
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applied exclusively, ions would collide with the electrodes. Therefore a compensation voltage 
refocuses the ions and this voltage is set to the properties of a desired ion type. Depending on 
the compensation voltage, specific ions are repelled in such a way as to traverse the device while 
other ions are removed. In this way, the FAIMS device is mostly used as a mobility filter, removing 
unwanted interfering ions, which enhances selectivity in combination with MS [168] due to their 
orthogonal separation principles. Note that CCSs cannot be determined by FAIMS because the 
electric field used exceeds the low-field limit.  
FAIMS can be combined with any type of mass spectrometer and is commercially available from 
Thermo Scientific and AB Sciex, amongst others.  
Table 1: Principle characteristics of the most wide-spread IMS devices (adapted from [169] and [155]) 
 DTIMS TWIMS FAIMS 
Drift gas yes yes yes 
Pressure Ambient (1 bar) 0.025-3 mbar Ambient (1 bar) 
Temperature Ambient ( 300 K) 360 K Ambient (300 K) 
    
Electric Field E Uniform low  Dynamic and non-uniform 
low  
Alternating asymmetric 
high/low  
Advantages  + CCS can be determined 
+ high resolution 
+ CCS can be determined 
+ separation of precursors 
and fragments 
+ high resolution 
+ combination with diverse 
mass spectrometer 
Disadvantages of IMS-
MS instruments 
+ separation only possible 
after ionization 
+ ion losses during transfer 
from atmospheric pressure 
to reduced pressure 
+ Calibration necessary 
+ low resolving power 
+ ion heating 
+ CCS cannot be 
determined 
+ separation only possible 
directly after ionization 
+ low usage of generated 
ions/only applicable for 
selected ions or ion 
mobility ranges 
 
1.3.5. Trapped Ion Mobility Spectrometry – Mass Spectrometry 
One of the latest developments in ion mobility spectrometry is trapped ion mobility spectrometry 
(TIMS), introduced by Park and co-workers at Bruker [123]. The TIMS analyzer consists of pairs 
of stacked electrodes and is divided into three regions: entrance funnel, TIMS tunnel, and exit 
funnel (Figure 14A). Due to the division of the TIMS analyzer into quadrants, it is possible to apply 
RF potentials independently to each quadrant [170, 171]. This creates a dipole field (for trapping 
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and focusing ions) in the entrance and exit funnel and a quadrupole field (for confining ions) in 
the TIMS tunnel. In addition, a DC field is superimposed on the RF field of the funnel and tunnel 
plates. This leads to an axial electric field gradient in the TIMS tunnel, which is set via a resistor 
divider chain. During TIMS analysis, a fixed DC potential is applied to the exit of the tunnel and a 
scanable voltage to the entrance of the tunnel. Therefore the mobility range, resolution and 
analysis speed is dependent on the settings of the entrance potential. In the entrance and exit 
funnels, the DC potential is responsible for pushing the ions downstream.  
During operation, ions are introduced to the TIMS analyzer through a glass capillary and they are 
then deflected into the entrance funnel. Then ions are guided through the very compact (around 
10 cm long) TIMS tunnel via a flow of gas, which drags them along in the presence of a 
counteracting electric field (Figures 14A and 14B). Depending on their mobility, ions rest at a 
position where the two forces are equal. Ions with larger CCS are close to the exit of the TIMS 
tunnel, whereas ions of smaller CCS are close to the entrance, the opposite of the separation 
order of DTIMS and TWIMS [123]. Ions are accumulated for a user-defined length of time in the 
TIMS tunnel, and they are then released or eluted by decreasing the electric field strength, in a 
manner that is also adjustable by the user [172].  
One major advantage of the TIMS device is that the mobility resolution is not dependent on the 
length of the tunnel and is easily adjustable [172]. The mobility resolution is controlled by the bath 
gas velocity and the electric field ramp speed and Park and co-workers showed that a resolution 
of > 200 in principle can be achieved [173]. Another very attractive feature of TIMS device is that 
due to its very compact configuration, it can be easily incorporated into different mass 
spectrometers such as the micrOTOF-Q instrument [123] or FT-ICR mass spectrometer [174] 
(both from Bruker Daltonics). Moreover the user can decide to measure with or without TIMS 
mode and can also adjust the duty cycle [172].  
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Figure 14: Principle of trapped ion mobility spectrometry (TIMS). (A) Schematic of the TIMS device. Ions 
coming from the capillary inlet are deflected by the deflection plate and enter the very compact (around 
10 cm in length) TIMS tunnel through the entrance funnel. Ions are stored in the TIMS tunnel and once 
released, enter the mass spectrometer via the exit funnel. (B) General TIMS operation mode, including 
ion accumulation and serial elution of ion mobility separated ions from the TIMS tunnel by decreasing 
the electric field gradient. Adapted from [175]. 
 
1.4. Applications of MS-based proteomics 
MS-based proteomics can be applied amongst others for the analysis of almost complete 
proteomes of model organisms such as yeast [176], for the analysis of post-translation 
modifications (PTMs) as well as for the investigation of protein-protein interactions. In addition to 
the global analysis of protein composition, MS-based proteomics can also quantify them. The 
detection of all existing proteins is difficult since a large number of proteins are only expressed at 
specific conditions and time points and vary from cell type to cell type. Dependent on the biological 
question, the analysis of a sub-proteome may be preferred. For example, for the investigation of 
protein-protein interactions, only the proteins of interest and their interacting partners are used 
from a crude protein mixture and for the study of PTMs only the corresponding sub-proteome is 
used. Another application of MS-based proteomics besides interaction proteomics and PTM-
related proteomics is clinical proteomics. Here, protein mixtures derived from patient material are 
used. The aim of clinical proteomics is to contribute to diagnosis and treatment of various 
diseases. 
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Mass spectrometry-based interaction proteomics: Identifying all molecular interactions of a 
biological system has been one goal in systems biology for a long time. Different approaches 
beside mass spectrometry have been developed to investigate protein-protein interactions [177, 
178].  A well-known workflow in MS-based interaction proteomics is the so-called affinity 
purification-mass spectrometry (AP-MS) approach [179]. Here, protein-protein interactions are 
investigated by immobilizing the protein of interest via an antibody or genetically encoded tag to 
an affinity matrix, before using it as a bait to capture its interacting proteins from the whole 
proteome. After several washing steps to eliminate unspecific interaction partners, the proteins 
that interact with the protein of interest are eluted from the matrix and analyzed in the mass 
spectrometer. AP-MS had some limitations such as the loss or under-representation of weak 
binding partners due to the washing steps in the sample preparation workflow or the 
misinterpretation of results since specific and unspecific binding interactors were not directly 
distinguishable. With the introduction of quantitative proteomics those limitation could have been 
largely solved [180, 181]. For example, isotopic labeling approaches made it possible to 
distinguish true interacting partners from unspecific binders. However, isotopic labeling is still 
difficult to perform on a large-scale. Therefore, protein-protein interactions are mostly performed 
by label-free quantification [182, 183]. In addition to protein-protein interactions MS-based 
interaction proteomics can investigate protein interactions with DNA and RNA. Moreover, it can 
be used to analyze the topology and stoichiometry of complexes by using chemical cross-linkers 
[184, 185]. 
Large-scale analysis of post-translational modifications (PTMs): Post-translational modifications 
play a major role in signal transduction. Mostly this involves not only the PTM change of one 
protein, but rather a cascade of PTM alterations. To understand the complete signaling network, 
global analysis of PTMs is performed. PTMs can easily be detected with mass spectrometry 
because if a PTM is present, it leads to a shift in the mass of the modified peptide. A large number 
of modifications are known, such as phosphorylation [186, 187], lysine acetylation [188, 189] or 
methylation [190]. But the analysis of PTMs is also very challenging, since modified peptides are 
generally very low abundant, making MS/MS spectra analysis more complicated and because 
database search becomes much larger when allowing potential modifications. For the global 
analysis of PTMs modified peptides are usually enriched to reduce the sample complexity, 
increase peptide amounts, increasing the probability for detection by LC-MS analysis. PTMs on 
peptides can be localized at different positions. Therefore, to localize PTMs with high confidence, 
high quality MS2 spectra are necessary to detect the relevant fragment ion. Post-data processing 
then provides a localization score for each PTM, which reflects the confidence of localizing the 
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PTM to a specific site. With current MS technology more than 10,000 phosphopeptides can be 
identified in a typical experiment [191].  
Mass spectrometry-based clinical proteomics: Over the last years improvements in MS 
instrumentation as well as in the entire proteomics workflow and in computational proteomics 
have made it possible to apply mass spectrometry to clinical proteomics. For example, MS-based 
proteomics could in principle be used to classify patients into treatment resistant and non-resistant 
groups. Moreover MS-based proteomics could in the future potentially be used for the 
measurement of disease relevant biomarkers [192], including troponin I that indicates a 
myocardial infarction [193]. In biomarker discovery blood, plasma and serum are the sources of 
choice because they are easily accessible from patients and apart from the typical plasma 
proteins they contain proteins from all tissues in the body since it has contact to them. In clinical 
practice immunoassays are used for routine quantitative analyses. However, immunoassays have 
limitations such that multiplexing is very limited or not possible and that isoforms cannot 
necessarily be distinguished. Therefore, MS-based proteomics is very attractive because it has 
the potential to address those limitations. Nevertheless, the analysis of the plasma proteome is 
also challenging for MS, for instance due to the high dynamic range of proteins in the blood 
plasma. Moreover, to use MS-based proteomics for clinical samples, a very reproducible, robust 
and high-throughput sample preparation workflow is necessary. Mass spectrometry in 
combination with immunoaffinity-based approaches, termed immunoaffinity-based-MS (IA-MS) is 
already applied for the quantification of biomarkers [194, 195]. Here, proteins of interest are first 
enriched by specific antibodies and then analyzed by targeted proteomic approaches. Like 
enzyme-linked immunosorbent assays, IA-MS only analyzes proteins of interest. With both 
techniques new biomarkers cannot be identified. This is in contrast to discovery proteomics, which 
has the potential to quantify known biomarkers but also identify and quantify new biomarkers 
[192]. Besides blood plasma, other body fluids or tissues are investigated in biomarker discovery. 
For example, urine is used for the diagnosis of diabetes or bladder cancer, or lavage fluid for lung 
diseases. Those have the analytical advantage that the difference in protein concentration is lower 
in comparison to blood plasma.  
In summary, MS-based proteomics is already successfully applied in several areas. It can be 
used to compare protein-protein interactions, detect changes in PTMs between different samples 
as well as classify patients dependent on their disease status. In the future it may have a great 
impact on personalized medicine, including better diagnose and treatment of patients.  
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1.5. Objectives 
Fundamental challenges in MS-based proteomics include the high sample complexity and the 
difference in protein concentration in a biological sample. Developments in mass spectrometers 
towards higher sensitivity, sequencing speed and resolution partly address these challenges, 
however, overcoming them remains a major goal of the field of MS-based proteomics and 
therefore continued improvements in MS technology are highly desirable.  
Quadrupole time-of-flight (QTOF) mass spectrometers are one of the two major instrument types 
used in proteomics. QTOFs are applied in different areas including metabolomics and the 
screening of small molecules. Today, for very deep proteome analyses the Orbitrap mass 
analyzers combined with a linear ion trap or quadrupole has become the workhorse in most 
laboratories due to their very high resolution and mass accuracy [55]. However, TOF technology 
has fundamental attractions, such as the very high scanning speed and the absence of space 
charge effects (which is a limitation of all trapping instruments) and therefore there is a great 
interest in the community to use QTOFs for deep shotgun proteomics analyses. To date, QTOF 
instrument have not achieved the performance of hybrid Orbitrap instruments. In this thesis, I 
have developed, improved and evaluated novel QTOF technologies for deep shotgun proteomics 
analyses.  
I started working on a novel benchtop quadrupole time-of flight (QTOF) mass spectrometer, the 
impact II from Bruker, for shotgun proteomics applications. This instrument features several new 
hardware developments such as a novel collision cell, reflectron and detector to improve the ion 
transmission efficiency and resolving power. In this thesis, I first describe and evaluate these new 
technologies and conclude that the increase in ion extraction and resolution was enormous 
compared to previous TOF instruments. The next goal was to investigate how reproducibly and 
deeply the proteome can be covered in a single run format with this instrument. For this purpose 
I measured peptide mixtures generated from a human cancer cell line (HeLa) and from yeast 
cells, standard samples in the proteomics community in a single run format. After establishing 
optimal instrument settings, I investigated the depth of the proteome achievable from HeLa after 
high-pH reversed-phase fractionation, a particularly effective way of pre-fractionation peptide 
mixtures [42, 43]. Tissues are more challenging to analyze by MS-based proteomics because 
they are composed of different cell types as well as extracellular matrix and I evaluated the 
instrument on a complex peptide mixture derived from murine cerebellum. Here, I achieved the 
highest proteome coverage reported with a QTOF instrument for any proteomics system so far.  
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In proteomics it is not just important to identify proteins but also to quantify them accurately. 
Therefore, I next investigated the reproducibility and accuracy of label-free quantification in 
diverse experiments. For instance, I determined the coefficients of variation (CVs) between three 
technical replicates, which yielded very low CVs, and analyzed the fold changes in a spike-in 
experiment, which likewise resulted in results very close to those expected from the mixing ratios. 
Finally, I analyzed haploid against diploid yeast and characterized overall proteome differences 
between diverse mouse cell lines, which demonstrated potential application areas of this 
instrument.  
In my second project, the QTOF from the first project was additionally equipped with trapped ion 
mobility spectrometry (TIMS) in front of the QTOF mass analyzer. As explained above, this 
separates ions based on their size-to-charge ratio in the TIMS device before separating them 
depending on their mass-to-charge ratio in the mass spectrometer. TIMS in combination with 
mass spectrometry has several potential advantages: improved signal-to-noise ratio as signal is 
concentrated while noise is distributed and improved precursor ion fraction values since 
precursors in the same quadrupole isolation window are separated by their differences in ion 
mobility. In a TIMS-MS/MS analysis, the quadrupole isolates a specific ion population within a 
complete TIMS scan (usually every 50 ms) for further fragmentation. However, this is not optimal 
because each different ion population elutes from the TIMS device within a few ms. Therefore, 
the aim of this project was to investigate if multiple precursors could be selected in a single TIMS 
scan, which would result in an increase in sequencing speed. First, the hardware requirements 
were established, including parameters that ensure high ion mobility resolution, efficient storage 
of precursor ions and extremely rapid switching of the quadrupole. In experiments involving direct 
infusion of a complex peptide mixture, four precursors instead of one could be selected in every 
TIMS scan, resulting in a four times higher sequencing speed. Finally, the effects of such an 
improvement were modelled for shotgun proteomics by using the HeLa data-set from the first 
project. We showed that this method, termed parallel accumulation – serial fragmentation 
(PASEF), could represent a large improvement in shotgun proteomics as 70% of the detectable 
peptide features could be targeted instead of around 20% without applying the PASEF method.    
In my third project, I investigated if TIMS combined with mass spectrometry could be applied for 
reducing the compression problem in isobaric tagging experiments described above. Clearly, ion 
mobility separation has the potential to separate the precursors present in the same isolation 
window by their ion mobility. In this project, I first have investigated which ion mobility resolution 
can be achieved by varying the release time from the TIMS device. Next, I modelled how often 
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co-isolation and co-fragmentation of peptides appear with and without applying TIMS-MS. 
Moreover, I investigated in a real TIMS-MS analyses of TMT 6-plex labeled complex peptide 
mixtures if a median resolution of 78 is sufficient for accurate quantification. This resolution 
already reduces the number of interfering peptides up to two-fold and additional improvements 
could help to further reduce the number of chimeric MS2 spectra.  
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2. RESULTS 
2.1. A novel QTOF mass spectrometer for shotgun proteomics analyses 
Scarlet Beck, Annette Michalski, Oliver Raether, Markus Lubeck, Stephanie Kaspar, Niels 
Goedecke, Carsten Baessmann, Daniel Hornburg, Florian Meier, Igor Paron, Nils A. Kulak, 
Juergen Cox, and Matthias Mann 
The Impact II, a Very High-Resolution Quadrupole Time-of-Flight Instrument (QTOF) for 
Deep Shotgun Proteomics 
Molecular & Cellular Proteomics, 2015 July; 14(7) 
 
Fundamental challenges of shotgun proteomics include the very large numbers of peptides that 
elute from the column simultaneously and peptide concentrations that vary by many orders of 
magnitude. To address these critical challenges, developments in instrumentation towards higher 
sensitivity, sequencing speed and resolving power have been made in recent decades. 
In MS-based proteomics two major types of instrumentation are used, the hybrid Orbitrap and 
QTOF mass spectrometers. TOF mass analyzers possess several advantages including higher 
sequencing speed and absence of space charge effects in comparison to trapping mass 
analyzers. However, for deep shotgun proteomics analyses hybrid Orbitrap mass spectrometers 
are used in the majority of laboratories worldwide due to their superior resolution and mass 
accuracy.  
In 2014, our laboratory started a close collaboration with Bruker Daltonics Inc. with the aim of co-
developing, improving and evaluating several hardware and software features of a novel QTOF 
mass spectrometer, termed impact II, for shotgun proteomics. This instrument features a new 
collision cell, reflectron and detector, which are described and evaluated in the following paper. 
With the improved collision cell twice as many ions can be extracted and developments on the 
reflectron and detector technologies yield 80% greater resolving power (40,000 at m/z 1222) 
compared to the previous model.  
The ion transmission efficiency in a QTOF instrument was previously unknown. Therefore we set 
out to measure the number of ions that successfully pass through the instrument – starting from 
where they enter the vacuum system to where they reach the detector. By direct infusion of a 
bovine serum albumin (BSA) or blank solution, the ion current difference between these two 
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conditions could be measured which established that a total of 10% of the BSA ions were 
detected. 
Motivated by this excellent proportion of detectable ions, I investigated the performance of the 
impact II for single shot analysis by analyzing complex peptide mixtures derived from a 
mammalian cell line and yeast, standard samples in the proteomic community. With optimized 
instrument settings and changes in the heated liquid chromatography system, I achieved high 
reproducibility (R2 > 0.99) and good proteome coverage (4800 proteins with a 90 min gradient). 
To evaluate the impact II for very deep proteome coverage, high-pH reverse-phase pre-
fractionation was performed. I identified more than 11,200 proteins in cerebellum, the deepest 
proteome coverage reported with a QTOF mass spectrometer so far.  
In MS-based proteomics it is important to quantify each identified protein. For this purpose, I also 
evaluated the instrument for label-free quantification in different experiments. After showing that 
very reproducible and accurate quantitation can be achieved, I next applied the QTOF-based 
workflow to two proteomic experimental questions. I analyzed diploid and haploid S. cerevisiae to 
detect proteome changes between them as well as different murine cell lines to perform global 
proteomic comparisons.  
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2.2. Increase in sequencing speed and sensitivity by using Parallel 
Accumulation – Serial Fragmentation on a TIMS-QTOF instrument 
Florian Meier*, Scarlet Beck*, Niklas Grassl, Markus Lubeck, Melvin A. Park, Oliver Raether, and 
Matthias Mann 
*contributed equally 
Parallel Accumulation – Serial Fragmentation (PASEF): Multiplying Sequencing Speed and 
Sensitivity by Synchronized Scans in a Trapped Ion Mobility Device 
Journal of Proteome Research, 2015 December; 14(12) 
 
The major bottleneck of the data-dependent acquisition mode is that a large number of peptides 
elute from the column at once, but peptides are selected and fragmented one by one. Over the 
last decades improvements in mass spectrometry have tried to address these challenges by an 
increase in sequencing speed and higher resolution. Nevertheless, only a limited number of 
peptides can be targeted by the mass spectrometer and even less are identified. Our group 
recently showed that under standard conditions only 16% of the eluted peptide features were 
targeted for fragmentation [114].  
In 2011, trapped ion mobility spectrometry (TIMS) was introduced by Park and co-workers at 
Bruker, which can easily be combined with mass spectrometry. As described in the introduction, 
the TIMS device consists of pairs of stacked electrodes to which an RF and DC field are applied. 
A gas flow drags the ions along as they enter the TIMS device through the tunnel until they 
experience an equal counteracting force due to an electric field. Depending on their size and 
shape, the ions rest at a specific position. After a pre-defined accumulation time, stored ions are 
released from the TIMS tunnel by decreasing the electric field strength. Ions with larger cross 
sections elute before the more compact ones.  
In this second project, Florian Meier and I teamed up with scientists from Bruker to develop a 
method on a TIMS-MS instrument that can drastically increase the sequencing speed and/or the 
sensitivity. Inspired by the adjustable elution profile of ions from the TIMS device, we were 
interested to see if it was possible to use multiple precursors in one TIMS scan (or TIMS-MS 
cycle) to multiply sequencing speed without losing sensitivity. For this purpose we first evaluated 
the necessary hardware requirements. Rise and lag times of the power supplies could be adjusted 
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so that the quadrupole switched on the sub-millisecond time scale. This means that the 
quadrupole could in principle target 12-20 precursors in the proteomic mass when using a TIMS 
scan time of 50 ms. The major bottleneck on our prototype was the time needed to calculate the 
quadrupole set values and the application of those values by the instrument controller. In the 
future this limitation could be circumvented by using a real time field-programmable gate array.  
After demonstrating that sub-millisecond switching times of the quadrupole are possible, we 
investigated an ESI-TIMS-MS analysis by direct infusion of a peptide mixture composed of alcohol 
dehydrogenase (ADH), BSA, enolase and phosphorylase b. Instead of one precursor, four 
precursors could be targeted in a TIMS scan time of 50 ms. We termed the method parallel 
accumulation – serial fragmentation (PASEF), since precursor ions are accumulated in parallel 
and released sequentially dependent on their ion mobility.   
Finally, we investigated the effect of such an increase in MS/MS speed by modeling the outcome 
on typical shotgun proteomics data. We observed that around 250,000 features were detected 
within a 90 min gradient and of those, 45,000 features were targeted without using PASEF. By 
applying PASEF, with a four-fold increase in sequencing speed, almost all peptide features could 
in principle be targeted. However due to the limit of detection of the mass spectrometer most of 
the low intensity peptides would not be identified. By using PASEF for increasing sequencing 
speed and simultaneously increasing sensitivity by targeting low intensity features repeatedly, we 
expect an increase of 300% of targeted and potentially identified peptide features with current 
hardware specifications.  
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2.3. Improving isobaric mass tagging quantification by trapped ion mobility 
mass spectrometry 
Scarlet Beck, Florian Meier, Heiner Koch, Oliver Raether, Markus Lubeck, Niels Goedecke, 
Juergen Cox, and Matthias Mann 
Reducing the ratio compression problem in isobaric mass tagging experiments by trapped 
ion mobility spectrometry (TIMS) – mass spectrometry 
In preparation 
 
A well-known problem associated with isobaric mass tagging as well as with data-dependent 
acquisition experiments is the interference of multiple precursors that is caused because the 
resolution of liquid chromatography and the mass isolation window is not enough to isolate each 
eluting peptide from each other.  
Different publication have investigated this problem because on the one hand it decreases the 
number of peptide identifications and on the other hand it leads to ratio distortion in isobaric mass 
tagging experiments. Several methods have been developed to eliminate the ratio compression 
problem, but they still have disadvantages such as longer duty cycles, resulting in less peptide 
identifications.  
Ion mobility mass spectrometry separates ions based on their ion mobility and m/z and therefore 
has the potential to reduce or even eliminate the generation of chimeric MS/MS spectra. In my 
third project, I have investigated if trapped ion mobility spectrometry (TIMS) - mass spectrometry 
(MS) can be used to reduce the ratio compression problem. For this purpose, I have first 
investigated which resolution can be achieved when applying TIMS by varying the release times. 
Then I have calculated the number of interfering peptides with and without applying TIMS. With a 
median ion mobility resolution of 78 the effect of interference could be reduced by two-fold. 
Several examples show that peptides that would not be distinguishable without applying TIMS, 
are now separated based on their ion mobility. Additional investigations determined that narrowing 
the isolation mass window or increasing the ion mobility resolution would help to further reduce 
interference.  
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SUMMARY 
Proteomics experiments can be multiplexed by isobaric tagging approaches such as the 
tandem mass tag (TMT) reagent. However, more than one precursor can contribute to the 
reporter ions, leading to a compression of the measured TMT ratios compared to the 
theoretically expected ones. Here we combine trapped ion mobility spectrometry – mass 
spectrometry (TIMS-MS) with isobaric labeling to reduce or eliminate ratio compression 
without compromising analysis speed or sensitivity. Release (ramp out time) from the 
TIMS device determine the ion mobility resolution. By using a ramp out time of 25 ms, 50 
ms, 75 ms and 100 ms, we achieved median mobility resolutions of 22, 42, 60 and 78 
respectively. To investigate the effect of ion mobility resolution on ratio compression, we 
assessed interfering ions within the volume elements defined by chromatographic peak 
width, mass selection window and ion mobility width. Choosing a mass selection window 
of 2 Th and an ion mobility resolution corresponding to 100 ms release time caused more 
than 70% of the volume elements to be free of co-isolated species. This is a vast 
improvement from not using TIMS, where this proportion was less than 30%. 
Correspondingly, TMT ratios in selected volume elements agreed with theoretically 
expected ones. We conclude that TIMS combined with TMT is a promising avenue for 
multiplexing in proteomics.   
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Mass spectrometry (MS)-based proteomics has emerged as a powerful tool for the identification 
and quantification of thousands of proteins in biological samples such as cell or tissue lysates [1, 
2]. Over the last years different quantification strategies have been developed [3] that can be 
categorized into label-free quantification, in which protein abundance is calculated based on 
peptide intensities across runs [4, 5] and label-based quantification, in which different natural 
isotopes are used to quantify combined samples within the same spectra, either at the full mass 
spectra (MS1) or at tandem mass spectra (MS/MS) level, based on reporter ions [6-9]. Depending 
on the labeling strategy and the available number of different labels, multiplexing of samples can 
reduce MS measurement time several-fold. In isobaric tagging methods such as isobaric tags for 
relative and absolute quantification (iTRAQ) [10] or tandem mass tag (TMT) [11], samples are 
combined only after digestion, potentially giving rise to artifactual quantitative differences caused 
by up front sample handling [3]. However, ratios can often be determined very consistent within 
the reporter ion patterns and therefore isobaric tagging strategies often have high precision of 
measurement.  
The main drawback of reporter ion based quantitation strategies is that co-isolation and co-
fragmentation of multiple peptides within a defined quadrupole isolation window leads to chimeric 
MS/MS spectra. While co-isolated peptides could be distinguished by backbone fragmentation, 
all of them contribute to the very same reporter ion channels. This leads to distortion of the 
measured reporter ion ratios in comparison to the theoretically expected ones [12-14]. As the 
peptide of interest is usually one with a non-equal reporter ion pattern, whereas the background 
is not regulated, this tends to produce an underestimation of the actual ratios, and this is termed 
the ‘ratio compression problem’.  
To overcome these challenges, different strategies have been developed in the last few years. 
Several groups have restricted the selection window of the precursor in the mass or elution 
dimension, have extensively fractionated peptide mixtures or have attempted to correct the 
reporter ion ratios for the observed precursor ion fraction (PIF) in the selection window [12, 15-
17]. However, none of these approaches have been entirely successful and as an example, a 
recent large-scale studies still reports a mean ratio underestimation by a factor two [18]. Two 
methods manipulate ions in the mass spectrometer by either changing their charge states [16] or 
further fragmenting one of the MS/MS fragments [13]. The latter method has been further refined 
by co-isolating several fragments, which increases sensitivity, however, potentially re-introduces 
ratio compression if they originate from different precursors [19]. This synchronous precursor 
selection (SPS) method, while not solving the ratio compression problems completely [20], 
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requires a very high end mass spectrometer and still has a relatively slow cycle time, but 
nevertheless has been shown to enable quite large scale, multiplexed measurements [21-23].  
It has recently been reported that ion mobility spectrometry in combination with mass 
spectrometry potentially decreases the number of co-isolated peptides. For example Shliaha et 
al. reported that travelling wave ion mobility spectrometry (TWIMS) - MS reduces reporter ions 
contamination [24]. However, TWIMS did not generally solve the ratio compression problem, 
perhaps due the limited ion mobility resolution currently achievable with this technology.  
Several different ion mobility principles have been developed over the last few years that can be 
combined with MS. One of the latest is trapped ion mobility spectrometry (TIMS), introduced by 
Park and co-workers in 2011 [25]. In TIMS, ions are separated in an ion tunnel based on size and 
shape (collision cross section). In contrast to other approaches, this is achieved by a gas flow that 
drags the different ion species through the TIMS tunnel, while they experience a counteracting 
force due to an electrical field, bringing them to rest at the specific position where the two forces 
balance. Attractive features of the TIMS device include its compact nature, low voltage 
requirements and the fact that its resolving power is tunable through the release time of the ions 
from the device [26-28].  
In this paper, we investigated the application of trapped ion mobility spectrometry (TIMS) in 
combination with quadrupole time-of-flight (QTOF) mass spectrometry for accurate quantification 
in isobaric tagging experiments. We observed that TIMS-MS removes the ratio compression 
problem in isobaric tagging experiments for a large majority of the peptides. 
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EXPERIMENTAL PROCEDURES 
Sample preparation of HeLa and yeast lysates: HeLa cells (ATCC, S3 subclones) were cultured 
in Dulbecco`s modified Eagle`s medium containing 10% fetal bovine serum, 20 mM glutamine 
and 1% penicillin-streptomycin (all from PAA Laboratories). 5 x 107 cells were centrifuged at 200 
x g for 10 min, washed once with cold phosphate buffered saline (PBS) and then centrifuged 
again. Supernatant was discarded and the cell pellet shock frozen in liquid nitrogen and stored at 
-80°C until further use.  
Yeast strain (BY4741) clones were seeded in 2 x 30 ml of YPD medium (including 2% glucose 
w/v) and were grown over night at 30 °C at 200 rpm. On the next day, 500 ml YPD (including 2% 
glucose w/v) were pre-warmed in a 3 l Erlenmeyer flask (with baffles) and were grown for 5-6 h 
at 30 °C at 200 rpm to OD600 0.8. Then 40 ml of the culture were pelleted at 3,500 g for 5 min at 
4 °C. Pellets were resuspended in 25 ml cold PBS and centrifuged at 3,500 g for 5 min at 4 °C. 
They were resuspended in 1 ml cold PBS and centrifuged again at 3,500 g for 5 min at 4 °C. 
Finally, they were snap frozen in liquid nitrogen and stored at -80 °C until further use. 
The cell pellets were resuspended in 1 % (w/v) sodium deoxycholate, 10 mM TCEP, 40 mM 2-
chloroacetamide (CAA), 100 mM Tris-HCl, pH 8.5 for cell lysis. Lysates were heated to 100 °C 
for 10 min at 1400 rpm to enhance protein denaturation and to stop protease and phosphatase 
activity. Lysates were homogenized 15 min in a bioruptor (Diagenode) and LysC (Wako 
Chemicals GmbH) was added 1:100 and incubated at 30 °C overnight. The samples were 
transferred to StageTips (Empore) [29] containing SDB-RPS material, and were washed two 
times with 200 µl isopropanol 1% TFA. Afterwards the StageTips were washed with 200 µl of 
0.2% TFA in ddH20 and samples were eluted in 60 µl of 1% (w/v) TAE buffer, 80% ACN. Samples 
were dried in a speedvac and stored at -20 °C until further use. They were then subjected to single 
shot LC-MS/MS or LC-TIMS-MS/MS measurements with or without previous labeling with TMT 
6-plex labeling reagent (Thermo Scientific).  
 
Labeling of HeLa and yeast lysates: The HeLa peptides or yeast peptides (see above) were 
dissolved in 35 µl 50 mM HEPES pH 8.5 and labeled with 5 µl of the six TMT labels, leading to a 
final concentration of 7.5 mM TMT reagent. Afterwards the samples were diluted with 0.1% FA to 
acidify them and to lower the concentration of ACN to 1%. Samples were combined in a ratio of 
10:10:10:0:0:0 (HeLa) and 10:4:1:1:4:10 (yeast). Labeled HeLa and yeast sample were dissolved 
in 0.1% FA and combined 1:1 (v:v).  The combined samples were desalted on StageTips. Briefly, 
 79 
 
they were equilibrated with 40 µl 0.1% FA, then the sample was loaded and washed two-times 
with 0.1% FA. Samples were eluted with 60% ACN, 0.1% FA and dried followed by storage at -
80 °C before further measurement. 
 
Trapped ion mobility spectrometry (TIMS) – mass spectrometry (MS): All analyses were 
performed on a prototype, high-resolution QTOF mass spectrometer equipped with a TIMS device 
(Fig. 1A). Detailed description of the TIMS device and QTOF mass spectrometer have been 
published before [26, 30, 31].  
 
LC-TIMS-MS/MS analysis: We used a trapping column set-up (PepMap pre-column, 2 cm x 100 
µm; Thermo Scientific) and a Dionex HPLC pump (Ultimate 3000 nRSLC, Thermo Scientific). 
They were on-line coupled to a prototype TIMS-QTOF instrument with a CaptiveSpray ion source 
(both Bruker Daltonics). Peptides were separated on a Pep-Map UHPLC column (50 cm x 75 µm, 
2 µm particles; Thermo Scientific) using a 90 min multistep ACN gradient (buffer A: 0.1% FA, 
buffer B 100% ACN in 0.1% FA). In the TIMS tunnel, ions were accumulated for 25 ms, and 
mobility separated. They were released from the TIMS device by ramping the entrance potential 
from 207 V to 77 V within 25, 50, 75 or 100 ms (219, 438, 657, 877 TOF scans of 114 µs each). 
We used nitrogen as a bath gas at 31 °C at a constant flow velocity. The ion mobility scale was 
calibrated using selected masses from ESI-L Tuning Mix (Agilent). After acquiring a full scan MS 
spectrum, the N most intense precursors (topN) were selected for fragmentation. To keep the 
duty cycle equal for the different ramp times, we used a top40 method for the 25 ms ramp time, 
top20 for 50 ms, top13 for 75 ms and top10 for 100 ms. The total cycle time was around 1.2 s. If 
no ion mobility separation was needed for the experiment, the TIMS tunnel was switched to the 
transmission only mode where it functions as a funnel.  
 
Data analysis: For the data analysis with the MaxQuant software (version 1.5.5.6) [32] with the 
Andromeda search engine [33], we cut all raw files into 5 min retention time slices by using a 
python script and performed the data processing only from retention 60 to 65. The peptide 
spectrum match and protein false discovery rates (FDR) were set to 1%. The minimum length of 
amino acids was specified to 7. We used an initial allowed mass deviation of the precursor ions 
of up to 70 ppm, which was then reduced by MaxQuant after time-dependent recalibration of the 
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precursor masses and allowed a fragment mass deviation of 35 ppm. We searched against the 
Uniprot human database (downloaded on June 21, 2014, containing 88,976 entries and 247 
contaminants). Enzyme specificity was set as C-terminal to lysine and arginine, also allowing 
cleavage at proline bonds and a maximum of two missed cleavages. Carbamidomethylation of 
cysteine was selected as fixed modification and N-terminal protein acetylation and methionine 
oxidation as variable modifications.  
Data were further analyzed with the MaxQuant Viewer and processed using the R statistical 
programming environment [34].  
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RESULTS AND DISCUSSION 
Reducing interference by trapped ion mobility spectrometry (TIMS) 
For the investigation of the interference problem in trapped ion mobility spectrometry (TIMS) – 
mass spectrometry (MS) we used a prototype QTOF mass spectrometer equipped with a TIMS 
device (Fig. 1A). Briefly, ions are generated in an electrospray source, transferred into the vacuum 
system through a glass capillary and deflected by 90° by the deflection plate before entering the 
entrance funnel of the TIMS device (total length around 14 cm). There ions are focused and further 
guided into the TIMS tunnel (10 cm long), where they are separated based on ion mobility. The 
TIMS tunnel is composed of stacked ring electrodes to which a radio-frequency field and an 
electrostatic field current field are applied. A gas flow at a pressure of about 2-3 mbar originating 
from the capillary drags the ions through the TIMS tunnel until they experience an equal 
countervailing force due to an opposing  electric field. Thus, ions remain at a specific position 
dependent on their mobility. Larger ions are positioned close to the exit of the tunnel, while very 
small or compact ion species are located at the entrance of the tunnel. After ions are accumulated 
for a specific time period, they are released by decreasing the electric field strength. Ion packages 
that elute from the TIMS tunnel are focused into the exit funnel of the TIMS device and guided 
through the transfer quadrupole. This is followed by the analytical quadrupole, where precursor 
ions can be selected for subsequent fragmentation in the collision cell. Then, ions are accelerated 
in the field-free flight tube by the orthogonal accelerator and are deflected by a reflectron before 
they are detected on an MCP detector coupled to a 10-bit digitizer. 
In liquid chromatography (LC)-tandem mass spectrometry (MS/MS) analysis a large number of 
peptides elute from the column simultaneously after separation by reversed-phase 
chromatography. If these ion species differ only slightly in mass, they are co-isolated by the 
quadrupole and co-fragmented in the collision cell, resulting in chimeric MS/MS spectra. Figure 
1B (upper panel) schematically illustrates the LC-MS/MS analysis of a pair of co-eluting peptides. 
These peptides are also co-isolated and co-fragmented, producing chimeric MS/MS spectra as 
well as chimeric reporter ion patterns. In LC-TIMS-MS/MS analyses, peptides that elute from the 
column are first separated dependent on their mobility before specific ions are selected by the 
quadrupole for further analysis. Figure 1B (lower panel) shows how separation based on their ion 
mobility followed by separate isolation and fragmentation, results in uncontaminated reporter ion 
spectra for each peptide. This additional dimension of separation based on collisional cross 
sections therefore has the potential to suppress the generation of chimeric MS/MS spectra 
partially or completely, without a reduction in sensitivity or analysis speed. 
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Figure 1: Trapped ion mobility spectrometry (TIMS) – mass spectrometry (MS).  (A) Scheme of the 
prototype TIMS-QTOF mass spectrometer. (B) Illustration of isobaric interference in LC-MS/MS and LC-
TIMS-MS/MS. Two co-eluting peptides of similar mass are co-isolated and co-fragmented, resulting in 
distorted reporter ion pattern. TIMS separates the peptides based on their ion mobility and fragments 
them separately, potentially resulting in interference free reporter ion measurement.  
 
Investigating interference at the MS level 
Shotgun proteomics data feature two dimensions at the MS level, the mass range and the 
retention time of the peptides eluting from the chromatographic column. Figure 2A illustrates the 
extremely high complexity of shotgun proteomics data acquired from a complete mammalian cell 
lysate separated over a two hour gradient. Zooming into a very dense range of the heat map 
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shows that a large number of peptide that elute from the column simultaneously only differ slightly 
in mass. A 2 Th precursor isolation window in the quadrupole co-fragments them in the collision 
cell. Those peptides all contribute to the reporter ion intensities in isobaric mass tagging 
experiments, resulting in in-accurate quantitation. In addition, chimeric MS/MS spectra can 
hamper peptide identifications, although some database search algorithm can identify from more 
than one peptide from one MS/MS spectrum. With the additional dimension of separation due to 
trapped ion mobility spectrometry, peptides are further separated based on their mobility. As an 
example, Figure 2B shows that within an isolation window of 2 Th peptides are distinguishable 
based on their difference in ion mobility but not on their m/z. Note, however, that the mass and 
the mobility are correlated because larger ions tend to have larger cross sections. Therefore, we 
wished to investigate how high the ion mobility resolution would need to be to meaningfully reduce 
the co-fragmentation problem.  
 
Figure 2: Peptide heat maps of a mammalian cell lysate. (A) LC-MS heat map and zoom showing a 
large number of co-eluting peptide features. (B) LC-TIMS-MS heat map showing nearly isobaric, co-
eluting peptides (i), ii), iii)) within an isolation window of 2 Th that are separated based on their 
mobility.  
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Investigating the interference problem in LC-TIMS-MS 
To investigate if TIMS-MS can be used to reduce the ratio compression problem to achieve 
accurate quantification ratios of peptides in isobaric mass tagging experiments, we first explored 
which ion mobility resolution can be achieved with the TIMS device in a typical proteomics 
experiment. We varied the release time for ions from the TIMS tunnel from 25 ms up to 100 ms, 
while keeping fill time constant at 25 ms (Fig. 3A). We calculated the resolution for all peptide 
features that were determined by the MaxQuant environment using standard settings within a 5 
min window (from retention time 60 min to 65 min). Within a 5 min window more than 450 MS 
spectra were acquired containing more than 10,000 peptide features. A release time of 25 ms 
yielded a median resolution of 22, which increased to 78 with a release time of 100 ms. Moreover, 
increasing ion mobility resolution leads to the detection of more peptide features. Next, we 
investigated how often co-isolation and co-fragmentation appears in LC-MS and LC-TIMS-MS 
analysis. For this purpose we used all the peptide features determined by MaxQuant from the LC-
TIMS-MS with a release time of 100 ms to assess co-eluting peptides in an isolation window of 2 
Th with and without applying TIMS. Figure 3B demonstrates that more than 70% of all detectable 
features show interference in an isolation window of 2 Th without the ion mobility separation 
dimension. When applying TIMS with a release time of 100 ms, peptide interference can be 
reduced by around two-fold.  
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Figure 3: (A) Increase in IMS resolution by increasing the ramp time of the TIMS device. (B) Alleviating 
the interference problem by applying TIMS-MS. Retention time interferences were counted within a +/-
FWHM of the retention time peak, MS interferences within a 2 Th window and ion mobility 
interferences within a 2 Th window and +/-FWHM of the ion mobility peak. 
 
Using a narrow isolation window should help to further reduce co-isolation and co-fragmention 
[35]. Therefore, we next modeled the effects of varying the isolation window from 2 Th to 0.1 Th 
on our data. Figure 4A shows that an isolation window of 0.1 Th would almost eliminate co-
isolation and co-fragmentation, however such an isolation window would be impractical due to a 
drastically reduced the ion transmission efficiency. Currently, an isolation window of between 1 to 
2 Th is common in MS-based proteomics, and with this isolation width up to 80% of peptide 
precursors are pure. With a release time of 100 ms, 30% of all peptide features still show 
distortion. Therefore we next investigated if a higher resolution could help to eliminate the 
interference problem completely. For this purpose, we calculated the number of interfering 
peptides within +/- 1 to +/- 0.1 times the mobility peak half width at full maximum (FWHM). Figure 
4B shows that very sharp peaks on the mobility axis would be necessary to completely eliminate 
the problem of co-isolation.   
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Figure 4: Reduction of interference by reducing the isolation window or mobility half width (FWHM). 
(A) Interferences dependent on the isolation window of the quadrupole. (B) Interferences dependent 
on the mobility half width. Selection of peptides in narrow ion mobility windows lowers the number of 
interfering peptides.  
 
Reporter ion decompression by TIMS  
To benchmark the TIMS-MS method for isobaric mass tagging experiments, we used a two-
proteome model yeast/HeLa to measure ratio distortion as described previously [13]. We digested 
a yeast sample with LysC and labeled separate aliquots using TMT 6-plex, and then mixed those 
at ratios of 10:4:1:1:4:10. We did the same with a HeLa lysate, but only labeled three aliquots and 
mixed them 10:10:10. Finally, we mixed the two labelled peptide mixtures in a 1:1 ratio. In this 
kind of experiment, co-isolation and co-fragmentation of TMT labeled yeast and HeLa peptides is 
clearly detectable (Figure 5, marked in green). Figure 5 shows an example in which ratio distortion 
is eliminated by applying TIMS.  
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Figure 5: Example of successful decompression of reporter ion patterns. The two co-eluting peptides 
marked in black in the MS spectrum are separated based on their mobility before isolation by a 
quadrupole mass isolation window of 2 Th. One peptide is derived from yeast (blue) with an expected 
ratio of 10:4:1:1:4:10 and the other peptide from HeLa with an expected ratio of 10:10:10 (red).  
 
CONCLUSION AND OUTLOOK 
Here, we have shown that coupling trapped ion mobility spectrometry (TIMS) to MS provides an 
additional dimension of separation based on mobility. By varying the release time (25 ms to 100 
ms) from the TIMS tunnel a resolution of 22 to 78 can be achieved. Further, we have 
demonstrated that even an ion mobility resolution of around 78 is still not sufficient to completely 
solve the ratio compression problem, however at least the interference of peptides can be reduced 
two-fold. A further increase in ion mobility resolution and using narrower isolation windows would 
help to further reduce interfering peptides. Furthermore, computational strategies could be applied 
to correct the ratios based on the observed patterns of changing ratios in ion mobility and 
chromatographic retention times.  
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3. CONCLUSION AND OUTLOOK 
In this thesis construction and performance of novel quadrupole time-of-flight mass spectrometers 
were described and evaluated for applications in shotgun proteomics. In the first project we have 
measured and modelled the ion transmission through the whole instrument starting from the 
capillary outlet to the detector for the first time. 10% of the ions are transferred, indicating excellent 
efficiency. Developments and improvements on the collision cell, reflectron and detector lead to 
an increase in ion transmission (up to two-fold) and in resolution (80% higher in comparison to 
the previous instrument). In the next step, we optimized the instrument settings and showed that 
performance is now comparable to other state-of-the-art mass spectrometers by analyzing yeast 
and HeLa peptide mixtures. For example, more than 4800 proteins of the HeLa proteome could 
be identified in a single run within a 90 min gradient with high reproducibility (90% of all identified 
proteins were detected in all replicates). In addition, I achieved the deepest proteome coverage 
that was reporter with a QTOF instrument so far. In proteomics experiments, a deep coverage of 
the proteome is of interest, but even more so the absolute or relative amount of proteins within 
each biological sample. Therefore, I also evaluated the instrument for label-free quantification. 
With the novel QTOF instrument accurate (measured fold change of 0.49 ± 0.06, theoretical ratio 
0.5) and reproducible quantification can be achieved. For 90% of the identified proteins the CV 
was below 10%. Moreover an R2 > 0.99 for triplicate analysis of Hela digests was achieved. I also 
have tested our workflow in biological contexts by comparing the proteome between diploid and 
haploid S. cerevisiae and by performing global proteomic comparison of different cell lines (spinal 
cord neuron-neuroblastoma, mouse hepatoma and mouse embryonic fibroblast cell lines). With 
a 90 min gradient in total 3769 proteins could be identified in quadruplicates. Our group has 
described the same system a few years ago using Orbitrap technology, but there much more start 
material was used and much more measurement time was needed. Therefore, we conclude that 
the Bruker QTOF instrument can be used for shotgun proteomics analyses of complex proteomes 
and with further developments and improvements coverage of the complete proteome could be 
achieved.  
Motivated by the positive outcome of the first project as well as the potential of ion mobility 
spectrometry, we continued developing and improving the described QTOF instrument described 
above. Due to their high sequencing speed, QTOFs can be easily combined with ion mobility 
spectrometry and this has several advantages. It improves the selectivity since co-eluting 
peptides with the same m/z can be separated based on differences in ion mobility. Moreover, by 
the additional dimension of separation the limit of detection can be improved by removing 
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background interference. An increase in speed can be achieved because peptides are separated 
much faster with IMS in comparison to LC. In the next project, we have equipped a QTOF mass 
spectrometer with a trapped ion mobility spectrometry (TIMS) device up-front the analytical 
quadrupole to investigate such an instrument for shotgun proteomics applications. More precisely 
we were interested if multiple precursors could be selected in a single TIMS scan, by Parallel 
Accumulation – Serial Fragmentation (PASEF). We showed that the hardware and firmware 
allowed sub-millisecond switching time of the quadrupole, which was important for PASEF to be 
applied. We next investigated the PASEF method in a complex protein digest. Instead of one 
precursor, we could target four, resulting in a four-fold sequencing speed increase. Modeling the 
effect of such an improvement for shotgun proteomics data suggests that twice as many peptide 
features can be successfully targeted. This increase in speed can be used to target more peptide 
features and to target low abundant peptides several time to increase sensitivity. This method 
therefore has the potential to solve the challenges of data-dependent MS-based proteomics 
nearly completely. All the measurements in the second project were performed by direct infuse 
the complex mixture. Therefore, the next step would be to apply it to LC-MS/MS measurements 
to realize the potential of the PASEF method in practice.  
In the last project I have applied TIMS-MS for the reduction of interfering peptides. I showed that 
a median resolution of 78 is not sufficient to eliminate the interference problem completely. 
However, using TIMS to MS reduces the number of interfering peptides up to two-fold. Moreover, 
I showed in a typical isobaric tagging experiment that peptides that slightly differ in mass can be 
distinguished based on their ion mobility, resulting in non-chimeric MS/MS spectra and avoiding 
ratio distortion. Further improvements on instrument settings such as reducing the mass isolation 
window or increasing the ion mobility resolution would help to further reduce interfering peptides.  
In summary, results described in this thesis clearly show the potential of quadrupole time-of-flight 
instruments for shotgun proteomics, especially when combining it with ion mobility spectrometry. 
With the QTOF mass spectrometry alone, already a very deep coverage of a proteome with high 
reproducibility was achieved. Combining such an instrument with TIMS will clearly increase the 
number of peptide and protein identifications. In addition by applying the PASEF method in TIMS-
MS the increase in sequencing speed will help to target more peptides for subsequent MS/MS 
spectra as well as increasing the sensitivity for shotgun proteomics experiments. Moreover, TIMS-
MS can be used for multiplexing, resulting in a decrease in MS measurement time and particularly 
has the potential for accurate quantification in isobaric labeling experiments. High specificity, 
sensitivity and throughput are all potentially provided by the TIMS-QTOF mass spectrometer and 
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this is important for in-depth profiling of complex protein mixtures such as human tissues or body 
fluids in clinical proteomics. For example, the chance to identify low abundant proteins in blood 
plasma is now increased by applying the PASEF method. Moreover, the increase in sensitivity 
could also be beneficial biomarker discovery since protein biomarker candidates may be present 
at the lower end of the plasma protein concentration range. Simultaneously, approaches for 
decreasing the sample complexity such as fractionation will in many cases not be necessary 
anymore, resulting in a reduction of MS measurement time. Likewise depletion of the high 
abundant plasma proteins, which may introduce a bias in the sample may not be necessary when 
applying TIMS-MS.  The increase in sequencing speed by PASEF can also be used to develop a 
mixed targeted and data-dependent acquisition. A great advantage here is that there is no need 
to develop peptide assays before the actual measurement, as is the case in SRM targeted 
proteomics. Using multiplexing strategies samples from large patient cohorts can be analyzed in 
a reasonable time. Combined with further developments and improvements in instrumental 
robustness and robust high-throughput sample preparation workflow will make MS-based 
proteomics ready for the clinics.  
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